1
|
Mejia MC, Kowalchuk A, Gonzalez S, Sunny A, Scamp N. Expanding Treatment, Recovery, and Reentry Services for Female Offenders: Improving Outcomes through Client-Centered Interventions. Community Ment Health J 2024; 60:713-721. [PMID: 38175318 DOI: 10.1007/s10597-023-01223-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Accepted: 12/22/2023] [Indexed: 01/05/2024]
Abstract
This study investigated the impact of a specialized program aimed at improving substance use disorder and trauma treatment, recovery, and reentry services for adult female offenders. Trained recovery coaches delivered pretreatment interventions such as prescreening, motivational interviewing, and support-building to facilitate treatment entry and improve outcomes. Of 113 participants, 40% identified as racial/ethnic minorities, and 72% fell within the 25-45 age range. A notable 44.5% reduction in self-reported psychiatric symptoms was observed, alongside significant improvements in abstinence and trauma symptoms. Recovery capital and psychosocial functioning showed marked improvement including significant changes in employment status and housing stability and a decrease in criminal justice involvement. The results suggest that targeted, client-centered approaches can effectively improve recovery and psychosocial functioning among female offenders while reducing re-incarceration rates. These findings underscore the importance of addressing the unique needs of this population in both pre-and post-release settings to ensure equitable access to reentry services.
Collapse
Affiliation(s)
- Maria Carmenza Mejia
- Department of Family and Community Medicine, Baylor College of Medicine, 3701 Kirby Dr., Suite 600, Houston, TX, 77098, USA.
| | - Alicia Kowalchuk
- Department of Family and Community Medicine, Baylor College of Medicine, 3701 Kirby Dr., Suite 600, Houston, TX, 77098, USA
| | - Sandra Gonzalez
- Department of Family and Community Medicine, Baylor College of Medicine, 3701 Kirby Dr., Suite 600, Houston, TX, 77098, USA
| | - Ajeesh Sunny
- Department of Family and Community Medicine, Baylor College of Medicine, 3701 Kirby Dr., Suite 600, Houston, TX, 77098, USA
| | | |
Collapse
|
2
|
Nicolás-Morala J, Alonso-Juarranz M, Barahona A, Terrén S, Cabezas S, Falahat F, Gilaberte Y, Gonzalez S, Juarranz A, Mascaraque M. Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells. Sci Rep 2024; 14:7025. [PMID: 38528037 DOI: 10.1038/s41598-024-57624-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2023] [Accepted: 03/20/2024] [Indexed: 03/27/2024] Open
Abstract
Cutaneous and Head and Neck squamous cell carcinoma (CSCC, HNSCC) are among the most prevalent cancers. Both types of cancer can be treated with photodynamic therapy (PDT) by using the photosensitizer Temoporfin in HNSCC and the prodrug methyl-aminolevulinate (MAL) in CSCC. However, PDT is not always effective. Therefore, it is mandatory to correctly approach the therapy according to the characteristics of the tumour cells. For this reason, we have used cell lines of CSCC (A431 and SCC13) and HNSCC (HN5 and SCC9). The results obtained indicated that the better response to MAL-PDT was related to its localization in the plasma membrane (A431 and HN5 cells). However, with Temoporfin all cell lines showed lysosome localization, even the most sensitive ones (HN5). The expression of mesenchymal markers and migratory capacity was greater in HNSCC lines compared to CSCC, but no correlation with PDT response was observed. The translocation to the nucleus of β-catenin and GSK3β and the activation of NF-κβ is related to the poor response to PDT in the HNSCC lines. Therefore, we propose that intracellular localization of GSK3β could be a good marker of response to PDT in HNSCC. Although the molecular mechanism of response to PDT needs further elucidation, this work shows that the most MAL-resistant line of CSCC is more sensitive to Temoporfin.
Collapse
Affiliation(s)
- J Nicolás-Morala
- Department of Biology, Universidad Autónoma de Madrid, Madrid, Spain
- Department of Experimental Dermatology and Skin Biology, Instituto Ramón y Cajal de Investigación Sanitaria, IRYCIS, 28034, Madrid, Spain
| | - M Alonso-Juarranz
- Oral and Maxillofacial Surgery Service, Hospital Clínico San Carlos, 28040, Madrid, Spain
- Surgery Department, Faculty of Medicine, Universidad Complutense, 28040, Madrid, Spain
| | - A Barahona
- Department of Biology, Universidad Autónoma de Madrid, Madrid, Spain
| | - S Terrén
- Department of Biology, Universidad Autónoma de Madrid, Madrid, Spain
| | - S Cabezas
- Oncology Service, Hospital Clínico San Carlos, 28040, Madrid, Spain
| | - F Falahat
- Oral and Maxillofacial Surgery Service, Hospital Clínico San Carlos, 28040, Madrid, Spain
- Surgery Department, Faculty of Medicine, Universidad Complutense, 28040, Madrid, Spain
| | - Y Gilaberte
- Department of Dermatology, Miguel Servet University Hospital, Instituto Investigación Sanitaria (IIS), Zaragoza, Aragón, Spain
| | - S Gonzalez
- Department of Experimental Dermatology and Skin Biology, Instituto Ramón y Cajal de Investigación Sanitaria, IRYCIS, 28034, Madrid, Spain
- Department of Medicine and Medical Specialties, Universidad de Alcalá, Madrid, Spain
| | - A Juarranz
- Department of Biology, Universidad Autónoma de Madrid, Madrid, Spain.
- Department of Experimental Dermatology and Skin Biology, Instituto Ramón y Cajal de Investigación Sanitaria, IRYCIS, 28034, Madrid, Spain.
| | - M Mascaraque
- Department of Biology, Universidad Autónoma de Madrid, Madrid, Spain.
- Department of Experimental Dermatology and Skin Biology, Instituto Ramón y Cajal de Investigación Sanitaria, IRYCIS, 28034, Madrid, Spain.
| |
Collapse
|
3
|
Peña-Valencia K, Riaño W, Herrera-Diaz M, López L, Marín D, Gonzalez S, Agudelo-García O, Rodríguez-Sabogal IA, Vélez L, Rueda ZV, Keynan Y. Markers of Inflammation, Tissue Damage, and Fibrosis in Individuals Diagnosed with Human Immunodeficiency Virus and Pneumonia: A Cohort Study. Pathogens 2024; 13:84. [PMID: 38251391 PMCID: PMC10820350 DOI: 10.3390/pathogens13010084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/25/2023] [Revised: 01/10/2024] [Accepted: 01/15/2024] [Indexed: 01/23/2024] Open
Abstract
Previous studies have noted that persons living with human immunodeficiency virus (HIV) experience persistent lung dysfunction after an episode of community-acquired pneumonia (CAP), although the underlying mechanisms remain unclear. We hypothesized that inflammation during pneumonia triggers increased tissue damage and accelerated pulmonary fibrosis, resulting in a gradual loss of lung function. We carried out a prospective cohort study of people diagnosed with CAP and/or HIV between 2016 and 2018 in three clinical institutions in Medellín, Colombia. Clinical data, blood samples, and pulmonary function tests (PFTs) were collected at baseline. Forty-one patients were included, divided into two groups: HIV and CAP (n = 17) and HIV alone (n = 24). We compared the concentrations of 17 molecules and PFT values between the groups. Patients with HIV and pneumonia presented elevated levels of cytokines and chemokines (IL-6, IL-8, IL-18, IL-1RA, IL-10, IP-10, MCP-1, and MIP-1β) compared to those with only HIV. A marked pulmonary dysfunction was evidenced by significant reductions in FEF25, FEF25-75, and FEV1. The correlation between these immune mediators and lung function parameters supports the connection between pneumonia-associated inflammation and end organ lung dysfunction. A low CD4 cell count (<200 cells/μL) predicted inflammation and lung dysfunction. These results underscore the need for targeted clinical approaches to mitigate the adverse impacts of CAP on lung function in this population.
Collapse
Affiliation(s)
- Katherine Peña-Valencia
- Escuela de Microbiología, Universidad de Antioquia, Medellin 050010, Colombia;
- Grupo de Investigación en Salud Pública, Facultad de Medicina, Universidad Pontificia Bolivariana, Medellin 050010, Colombia; (W.R.); (L.L.); (D.M.); (Z.V.R.)
- Grupo Bacterias & Cáncer, School of Medicine, Universidad de Antioquia, Medellin 050010, Colombia;
| | - Will Riaño
- Grupo de Investigación en Salud Pública, Facultad de Medicina, Universidad Pontificia Bolivariana, Medellin 050010, Colombia; (W.R.); (L.L.); (D.M.); (Z.V.R.)
- School of Medicine, Universidad de Antioquia, Medellin 050010, Colombia;
| | - Mariana Herrera-Diaz
- Department of Medical Microbiology and Infectious Disease, University of Manitoba, Winnipeg, MB R3E 0J9, Canada; (M.H.-D.); (S.G.)
| | - Lucelly López
- Grupo de Investigación en Salud Pública, Facultad de Medicina, Universidad Pontificia Bolivariana, Medellin 050010, Colombia; (W.R.); (L.L.); (D.M.); (Z.V.R.)
- School of Medicine, Universidad Pontificia Bolivariana, Medellin 050010, Colombia
| | - Diana Marín
- Grupo de Investigación en Salud Pública, Facultad de Medicina, Universidad Pontificia Bolivariana, Medellin 050010, Colombia; (W.R.); (L.L.); (D.M.); (Z.V.R.)
- School of Medicine, Universidad Pontificia Bolivariana, Medellin 050010, Colombia
| | - Sandra Gonzalez
- Department of Medical Microbiology and Infectious Disease, University of Manitoba, Winnipeg, MB R3E 0J9, Canada; (M.H.-D.); (S.G.)
- JC Wilt Infectious Diseases Research Center, Winnipeg, MB R3E 3L5, Canada
| | - Olga Agudelo-García
- Grupo Bacterias & Cáncer, School of Medicine, Universidad de Antioquia, Medellin 050010, Colombia;
| | - Iván Arturo Rodríguez-Sabogal
- School of Medicine, Universidad de Antioquia, Medellin 050010, Colombia;
- Infectious Diseases Section, Hospital Universitario San Vicente Fundación, Medellin 050010, Colombia;
| | - Lázaro Vélez
- Infectious Diseases Section, Hospital Universitario San Vicente Fundación, Medellin 050010, Colombia;
| | - Zulma Vanessa Rueda
- Grupo de Investigación en Salud Pública, Facultad de Medicina, Universidad Pontificia Bolivariana, Medellin 050010, Colombia; (W.R.); (L.L.); (D.M.); (Z.V.R.)
- Department of Medical Microbiology and Infectious Disease, University of Manitoba, Winnipeg, MB R3E 0J9, Canada; (M.H.-D.); (S.G.)
| | - Yoav Keynan
- Department of Medical Microbiology and Infectious Disease, University of Manitoba, Winnipeg, MB R3E 0J9, Canada; (M.H.-D.); (S.G.)
- Grupo Investigador de Problemas en Enfermedades Infecciosas-GRIPE, Facultad de Medicina, Universidad de Antioquia, Medellin 050010, Colombia
- Department of Internal Medicine, University of Manitoba, Winnipeg, MB R3E 0J9, Canada
- Department of Community Health Sciences, University of Manitoba, Winnipeg, MB R3E 0J9, Canada
| |
Collapse
|
4
|
Vazquez C, Fonseca V, de la Fuente AG, Gonzalez S, Fleitas F, Lima M, Guimarães NR, Iani FCM, Rojas A, Alfonso T, Cantero C, Barrios J, Villalba S, Ortega MJ, Torales J, Gamarra ML, Aquino C, Franco L, Rico JM, Alcantara LCJ, Giovanetti M. Exploring the Genomic Dynamics of the Monkeypox Epidemic in Paraguay. Viruses 2024; 16:83. [PMID: 38257783 PMCID: PMC10821367 DOI: 10.3390/v16010083] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Revised: 11/29/2023] [Accepted: 12/01/2023] [Indexed: 01/24/2024] Open
Abstract
In recent months, Paraguay has been grappled with a notable monkeypox outbreak, straining its healthcare infrastructure. The sudden spike in cases underlines the imperative need for a comprehensive understanding of the virus's dynamics, enabling the formulation of robust containment measures. To address this challenge, our team joined forces with the Central Public Health Laboratory of Asunción and the Pan-American Health Organization. Through this collaboration, we employed portable whole-genome sequencing combined with phylodynamic analysis to examine the MPXV strains circulating in Paraguay. Our genomic monitoring approach has produced the first 30 whole-genome sequences from Paraguay, all of which were identified under lineage IIb. Interestingly, our data suggest that the origin of the monkeypox virus in Paraguay at the beginning of 2022 can be traced back to Brazil. This introduction subsequently catalyzed further community spread that was further exacerbated by several independent introduction events as time progressed. These findings not only shed light on the transmission patterns of the virus but also highlight the pivotal role such insights play in sculpting effective response strategies and driving impactful public health measures. Furthermore, our findings strongly advocate intensified surveillance at international borders, ensuring swift detection and proactive countermeasures against potential outbreaks in the future.
Collapse
Affiliation(s)
- Cynthia Vazquez
- Laboratorio Central de Salud Pública, Asunción 001535, Paraguay; (C.V.); (A.G.d.l.F.); (S.G.); (F.F.); (A.R.); (T.A.); (C.C.); (J.B.); (S.V.); (M.J.O.); (J.T.); (M.L.G.); (C.A.)
| | - Vagner Fonseca
- Coordenação de Vigilância, Preparação e Resposta à Emergências e Desastres (PHE), Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS), Brasilia 70312-970, Brazil
- Department of Exact and Earth Sciences, University of the State of Bahia, Salvador 41150-000, Brazil
| | - Andrea Gomez de la Fuente
- Laboratorio Central de Salud Pública, Asunción 001535, Paraguay; (C.V.); (A.G.d.l.F.); (S.G.); (F.F.); (A.R.); (T.A.); (C.C.); (J.B.); (S.V.); (M.J.O.); (J.T.); (M.L.G.); (C.A.)
| | - Sandra Gonzalez
- Laboratorio Central de Salud Pública, Asunción 001535, Paraguay; (C.V.); (A.G.d.l.F.); (S.G.); (F.F.); (A.R.); (T.A.); (C.C.); (J.B.); (S.V.); (M.J.O.); (J.T.); (M.L.G.); (C.A.)
| | - Fatima Fleitas
- Laboratorio Central de Salud Pública, Asunción 001535, Paraguay; (C.V.); (A.G.d.l.F.); (S.G.); (F.F.); (A.R.); (T.A.); (C.C.); (J.B.); (S.V.); (M.J.O.); (J.T.); (M.L.G.); (C.A.)
| | - Mauricio Lima
- Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, Brazil; (M.L.); (N.R.G.); (F.C.M.I.)
| | - Natália R. Guimarães
- Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, Brazil; (M.L.); (N.R.G.); (F.C.M.I.)
| | - Felipe C. M. Iani
- Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, Brazil; (M.L.); (N.R.G.); (F.C.M.I.)
| | - Analia Rojas
- Laboratorio Central de Salud Pública, Asunción 001535, Paraguay; (C.V.); (A.G.d.l.F.); (S.G.); (F.F.); (A.R.); (T.A.); (C.C.); (J.B.); (S.V.); (M.J.O.); (J.T.); (M.L.G.); (C.A.)
| | - Tania Alfonso
- Laboratorio Central de Salud Pública, Asunción 001535, Paraguay; (C.V.); (A.G.d.l.F.); (S.G.); (F.F.); (A.R.); (T.A.); (C.C.); (J.B.); (S.V.); (M.J.O.); (J.T.); (M.L.G.); (C.A.)
| | - Cesar Cantero
- Laboratorio Central de Salud Pública, Asunción 001535, Paraguay; (C.V.); (A.G.d.l.F.); (S.G.); (F.F.); (A.R.); (T.A.); (C.C.); (J.B.); (S.V.); (M.J.O.); (J.T.); (M.L.G.); (C.A.)
| | - Julio Barrios
- Laboratorio Central de Salud Pública, Asunción 001535, Paraguay; (C.V.); (A.G.d.l.F.); (S.G.); (F.F.); (A.R.); (T.A.); (C.C.); (J.B.); (S.V.); (M.J.O.); (J.T.); (M.L.G.); (C.A.)
| | - Shirley Villalba
- Laboratorio Central de Salud Pública, Asunción 001535, Paraguay; (C.V.); (A.G.d.l.F.); (S.G.); (F.F.); (A.R.); (T.A.); (C.C.); (J.B.); (S.V.); (M.J.O.); (J.T.); (M.L.G.); (C.A.)
| | - Maria Jose Ortega
- Laboratorio Central de Salud Pública, Asunción 001535, Paraguay; (C.V.); (A.G.d.l.F.); (S.G.); (F.F.); (A.R.); (T.A.); (C.C.); (J.B.); (S.V.); (M.J.O.); (J.T.); (M.L.G.); (C.A.)
| | - Juan Torales
- Laboratorio Central de Salud Pública, Asunción 001535, Paraguay; (C.V.); (A.G.d.l.F.); (S.G.); (F.F.); (A.R.); (T.A.); (C.C.); (J.B.); (S.V.); (M.J.O.); (J.T.); (M.L.G.); (C.A.)
| | - Maria Liz Gamarra
- Laboratorio Central de Salud Pública, Asunción 001535, Paraguay; (C.V.); (A.G.d.l.F.); (S.G.); (F.F.); (A.R.); (T.A.); (C.C.); (J.B.); (S.V.); (M.J.O.); (J.T.); (M.L.G.); (C.A.)
| | - Carolina Aquino
- Laboratorio Central de Salud Pública, Asunción 001535, Paraguay; (C.V.); (A.G.d.l.F.); (S.G.); (F.F.); (A.R.); (T.A.); (C.C.); (J.B.); (S.V.); (M.J.O.); (J.T.); (M.L.G.); (C.A.)
| | - Leticia Franco
- Infectious Hazards Management, Health Emergencies Department (PHE), Pan American Health Organization/World Health Organization (PAHO/WHO), Washington, DC 20037, USA; (L.F.); (J.M.R.)
| | - Jairo Mendez Rico
- Infectious Hazards Management, Health Emergencies Department (PHE), Pan American Health Organization/World Health Organization (PAHO/WHO), Washington, DC 20037, USA; (L.F.); (J.M.R.)
| | - Luiz Carlos Junior Alcantara
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, Brazil
- Climate Amplified Diseases and Epidemics (CLIMADE), University of Washington, Seattle, WA 98195, USA
| | - Marta Giovanetti
- Climate Amplified Diseases and Epidemics (CLIMADE), University of Washington, Seattle, WA 98195, USA
- Oswaldo Cruz Foundation (FIOCRUZ), Salvador, Bahia 40296-710, Brazil
- Sciences and Technologies for Sustainable Development and One Health, University of Campus Bio-Medico, 00128 Rome, Italy
| |
Collapse
|
5
|
Bernales M, Cordón P, Gonzalez S, Pedrero V, Ferrer L. Interaction among health workers and trans men: Findings from a qualitative study in Chile. J Nurs Scholarsh 2024; 56:142-152. [PMID: 37140134 DOI: 10.1111/jnu.12904] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2022] [Revised: 03/15/2023] [Accepted: 04/19/2023] [Indexed: 05/05/2023]
Abstract
PURPOSE To explore trans men's access and use of healthcare services in Chile, based on the experiences of the trans men themselves, as well as of healthcare professionals. METHODS A qualitative study with an ethnographic approach was carried out with 30 participants: 14 trans men and 16 healthcare professionals. Semi-structured one-on-one interviews with open-ended questions were used to collect the data. A thematic analysis was carried out with the NVivo Software. RESULTS Three main themes were identified: (1) failures in the recognition of trans identity, (2) challenges with patient-centered care, and (3) use of other ("non-trans") health services. CONCLUSIONS The results suggest that not all transition processes are the same, individuals seek different ways; therefore, it is necessary to consider different body types and identities when planning programs and care for men in transition. Moreover, the accompaniment provided during the gender transition process should contemplate emotional and mental support. CLINICAL RELEVANCE The study outlines the need for all healthcare professionals to have training and knowledge about the transgender population, regardless of whether they are part of the teams supporting gender transition processes. The role of nurses and the contributions that can be made from nursing discipline in this research field are fundamental.
Collapse
Affiliation(s)
- M Bernales
- School of Nursing, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - P Cordón
- School of Psychology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - S Gonzalez
- School of Psychology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - V Pedrero
- School of Nursing, Universidad Andres Bello, Santiago, Chile
| | - L Ferrer
- School of Nursing, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
| |
Collapse
|
6
|
Velez ID, Tanamas SK, Arbelaez MP, Kutcher SC, Duque SL, Uribe A, Zuluaga L, Martínez L, Patiño AC, Barajas J, Muñoz E, Mejia Torres MC, Uribe S, Porras S, Almanza R, Pulido H, O’Neill SL, Santacruz-Sanmartin E, Gonzalez S, Ryan PA, Denton JA, Jewell NP, Dufault SM, Simmons CP, Anders KL. Reduced dengue incidence following city-wide wMel Wolbachia mosquito releases throughout three Colombian cities: Interrupted time series analysis and a prospective case-control study. PLoS Negl Trop Dis 2023; 17:e0011713. [PMID: 38032857 PMCID: PMC10688673 DOI: 10.1371/journal.pntd.0011713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2023] [Accepted: 10/10/2023] [Indexed: 12/02/2023] Open
Abstract
BACKGROUND The introduction of Wolbachia (wMel strain) into Aedes aegypti mosquitoes reduces their capacity to transmit dengue and other arboviruses. Randomised and non-randomised studies in multiple countries have shown significant reductions in dengue incidence following field releases of wMel-infected Ae. aegypti. We report the public health outcomes from phased, large-scale releases of wMel-Ae. aegypti mosquitoes throughout three contiguous cities in the Aburrá Valley, Colombia. METHODOLOGY/PRINCIPAL FINDINGS Following pilot releases in 2015-2016, staged city-wide wMel-Ae. aegypti deployments were undertaken in the cities of Bello, Medellín and Itagüí (3.3 million people) between October 2016 and April 2022. The impact of the Wolbachia intervention on dengue incidence was evaluated in two parallel studies. A quasi-experimental study using interrupted time series analysis showed notified dengue case incidence was reduced by 95% in Bello and Medellín and 97% in Itagüí, following establishment of wMel at ≥60% prevalence, compared to the pre-intervention period and after adjusting for seasonal trends. A concurrent clinic-based case-control study with a test-negative design was unable to attain the target sample size of 63 enrolled virologically-confirmed dengue (VCD) cases between May 2019 and December 2021, consistent with low dengue incidence throughout the Aburrá Valley following wMel deployments. Nevertheless, VCD incidence was 45% lower (OR 0.55 [95% CI 0.25, 1.17]) and combined VCD/presumptive dengue incidence was 47% lower (OR 0.53 [95% CI 0.30, 0.93]) among participants resident in wMel-treated versus untreated neighbourhoods. CONCLUSIONS/SIGNIFICANCE Stable introduction of wMel into local Ae. aegypti populations was associated with a significant and sustained reduction in dengue incidence across three Colombian cities. These results from the largest contiguous Wolbachia releases to-date demonstrate the real-world effectiveness of the method across large urban populations and, alongside previously published results, support the reproducibility of this effectiveness across different ecological settings. TRIAL REGISTRATION NCT03631719.
Collapse
Affiliation(s)
- Ivan Dario Velez
- World Mosquito Program, Universidad de Antioquia, Medellín, Colombia
| | | | | | | | - Sandra L. Duque
- World Mosquito Program, Universidad de Antioquia, Medellín, Colombia
| | - Alexander Uribe
- World Mosquito Program, Universidad de Antioquia, Medellín, Colombia
| | - Lina Zuluaga
- World Mosquito Program, Universidad de Antioquia, Medellín, Colombia
| | - Luis Martínez
- World Mosquito Program, Universidad de Antioquia, Medellín, Colombia
| | | | - Jovany Barajas
- World Mosquito Program, Universidad de Antioquia, Medellín, Colombia
| | - Estefanía Muñoz
- World Mosquito Program, Universidad de Antioquia, Medellín, Colombia
| | | | - Sandra Uribe
- World Mosquito Program, Universidad de Antioquia, Medellín, Colombia
| | - Sandra Porras
- World Mosquito Program, Universidad de Antioquia, Medellín, Colombia
| | | | | | | | | | - Sandra Gonzalez
- World Mosquito Program, Universidad de Antioquia, Medellín, Colombia
| | - Peter A. Ryan
- World Mosquito Program, Monash University, Melbourne, Australia
| | - Jai A. Denton
- World Mosquito Program, Monash University, Melbourne, Australia
| | - Nicholas P. Jewell
- Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom
| | - Suzanne M. Dufault
- Division of Biostatistics, Department of Epidemiology and Biostatistics, University of California, San Francisco, California, United States of America
| | | | | |
Collapse
|
7
|
Edwards C, Dooley FC, Gonzalez S, Austin TM, Gravenstein N. A Single-Center Retrospective Review of Patients with Suspected Malignant Hyperthermia Susceptibility. Cureus 2023; 15:e44661. [PMID: 37799222 PMCID: PMC10550243 DOI: 10.7759/cureus.44661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/04/2023] [Indexed: 10/07/2023] Open
Abstract
Purpose The diagnosis of malignant hyperthermia susceptibility (MHS) has significant implications for the perioperative period that may persist for generations. Anesthetic medication options are reduced, anesthetic workstations require preparation to reduce exposure to inhaled volatile anesthetics, and patients may be excluded from surgery at ambulatory centers. In this study, we sought to better characterize the etiology of MHS diagnoses in our health system and the downstream effects of this diagnosis on anesthetic care. Methods We retrospectively reviewed the electronic medical records of 55 patients with a documented concern for MHS who received care at University of Florida (UF) Health between 2014 and 2020. We characterized the etiology of the patient's MHS diagnosis, whether this diagnosis was supported by formal genetic or muscle contracture testing, and the details of the recorded anesthetics that were delivered to these patients. Results The 55 patients with suspected MHS were evenly split between those with a family history of malignant hyperthermia (MH) (28/55) and those with a concern for MHS in their personal medical history (27/55). Of the 28 patients with a family history of MH, 16 reported that the affected family member was a first-degree relative, and two of these 16 reported that the affected family member had undergone confirmatory muscle contracture testing. Of the 27 patients with a personal history suspicious for MHS, two had undergone confirmatory genetic testing, and two patients had anesthetic records available for review where intraoperative MH was suspected and treated with dantrolene. An additional four patients were told of a concern about MHS due to another underlying diagnosis. No patients with a personal history suspicious of MHS had undergone confirmatory muscle contracture testing. These 55 patients underwent 87 anesthetics, and exclusively non-triggering anesthetic techniques were utilized in nearly all cases. In pediatric patients, some perioperative challenges were identified, related to the avoidance of mask inhalational induction. Only six of these 87 anesthetics occurred at our ambulatory surgery centers, a proportion (6.9%) lower than that of the general surgical population at UF Health (20.0%). Conclusions Among patients suspected to be MH susceptible in our health system over a six-year period, a minority (8/55) were supported by clear records of a prior MH event, confirmatory genetic or muscle contracture testing, or an underlying diagnosis closely linked to MH. The vast majority had limited documentation supporting their MH risk but continued to be treated with non-triggering anesthetics and were less likely to have surgery at an ambulatory surgery center than our overall surgical population. Among pediatric patients, some anesthetic challenges related to delivering non-triggering anesthetics were identified. Improving the documentation of index cases of MH and increasing referrals to clinical geneticists and genetic testing may be a viable route to decreasing the proportion of suspected MHS patients with a poorly characterized risk profile.
Collapse
Affiliation(s)
- Chris Edwards
- Anesthesiology, University of Florida College of Medicine, Gainesville, USA
| | - Fred C Dooley
- Anesthesiology, University of Florida College of Medicine, Gainesville, USA
| | - Sandra Gonzalez
- Anesthesiology, University of Florida College of Medicine, Gainesville, USA
| | - Thomas M Austin
- Anesthesiology, University of Florida College of Medicine, Gainesville, USA
| | | |
Collapse
|
8
|
Breine A, Van Holsbeeck K, Martin C, Gonzalez S, Mannes M, Pardon E, Steyaert J, Remaut H, Ballet S, Van der Henst C. Bypassing the Need for Cell Permeabilization: Nanobody CDR3 Peptide Improves Binding on Living Bacteria. Bioconjug Chem 2023. [PMID: 37418494 PMCID: PMC10360062 DOI: 10.1021/acs.bioconjchem.3c00116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/09/2023]
Abstract
Membrane interaction constitutes to be an essential parameter in the mode of action of entities such as proteins, as well as cell-penetrating and antimicrobial peptides, resulting in noninvasive or lytic activities depending on the membrane compositions and interactions. Recently, a nanobody able to interact with the top priority, multidrug-resistant bacterial pathogen Acinetobacter baumannii was discovered, although binding took place with fixed cells only. To potentially overcome this limitation, linear peptides corresponding to the complementarity-determining regions (CDR) were synthesized and fluorescently labeled. Microscopy data indicated clear membrane interactions of the CDR3 sequence with living A. baumannii cells, indicating both the importance of the CDR3 as part of the parent nanobody paratope and the improved binding ability and thus avoiding the need for permeabilization of the cells. In addition, cyclization of the peptide with an additionally introduced rigidifying 1,2,3-triazole bridge retains its binding ability while proteolytically protecting the peptide. Overall, this study resulted in the discovery of novel peptides binding a multidrug-resistant pathogen.
Collapse
Affiliation(s)
- A Breine
- Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, 1050 Brussels, Belgium
- Structural Biology Brussels, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium
| | - K Van Holsbeeck
- Research Group of Organic Chemistry, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium
| | - C Martin
- Research Group of Organic Chemistry, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium
| | - S Gonzalez
- CNRS, BioCIS, CY Cergy-Paris Université, 95000 Neuville sur Oise, France
| | - M Mannes
- Research Group of Organic Chemistry, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium
| | - E Pardon
- Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, 1050 Brussels, Belgium
- Structural Biology Brussels, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium
| | - J Steyaert
- Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, 1050 Brussels, Belgium
- Structural Biology Brussels, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium
| | - H Remaut
- Structural Biology Brussels, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium
- Structural and Molecular Microbiology, Structural Biology Research Center, VIB, 1050 Brussels, Belgium
| | - S Ballet
- Research Group of Organic Chemistry, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium
| | - C Van der Henst
- Microbial Resistance and Drug Discovery, VIB-VUB Center for Structural Biology, VIB, Flanders Institute for Biotechnology, 1050 Brussels, Belgium
- Structural Biology Brussels, Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels, Belgium
| |
Collapse
|
9
|
Lacey KA, Serpas L, Makita S, Wang Y, Rashidfarrokhi A, Soni C, Gonzalez S, Moreira A, Torres VJ, Reizis B. Secreted mammalian DNases protect against systemic bacterial infection by digesting biofilms. J Exp Med 2023; 220:e20221086. [PMID: 36928522 PMCID: PMC10037111 DOI: 10.1084/jem.20221086] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Revised: 01/18/2023] [Accepted: 03/01/2023] [Indexed: 03/18/2023] Open
Abstract
Extracellular DNase DNASE1L3 maintains tolerance to self-DNA in humans and mice, whereas the role of its homolog DNASE1 remains controversial, and the overall function of secreted DNases in immunity is unclear. We report that deletion of murine DNASE1 neither caused autoreactivity in isolation nor exacerbated lupus-like disease in DNASE1L3-deficient mice. However, combined deficiency of DNASE1 and DNASE1L3 rendered mice susceptible to bloodstream infection with Staphylococcus aureus. DNASE1/DNASE1L3 double-deficient mice mounted a normal innate response to S. aureus and did not accumulate neutrophil extracellular traps (NETs). However, their kidneys manifested severe pathology, increased bacterial burden, and biofilm-like bacterial lesions that contained bacterial DNA and excluded neutrophils. Furthermore, systemic administration of recombinant DNASE1 protein during S. aureus infection rescued the mortality of DNase-deficient mice and ameliorated the disease in wild-type mice. Thus, DNASE1 and DNASE1L3 jointly facilitate the control of bacterial infection by digesting extracellular microbial DNA in biofilms, suggesting the original evolutionary function of secreted DNases as antimicrobial agents.
Collapse
Affiliation(s)
- Keenan A. Lacey
- Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA
| | - Lee Serpas
- Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA
| | - Sohei Makita
- Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA
| | - Yueyang Wang
- Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA
| | - Ali Rashidfarrokhi
- Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA
| | - Chetna Soni
- Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA
| | - Sandra Gonzalez
- Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA
| | - Andre Moreira
- Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA
| | - Victor J. Torres
- Department of Microbiology, New York University Grossman School of Medicine, New York, NY, USA
- Antimicrobial-Resistant Pathogens Program, New York University Grossman School of Medicine, New York, NY, USA
| | - Boris Reizis
- Department of Pathology, New York University Grossman School of Medicine, New York, NY, USA
| |
Collapse
|
10
|
St. John A, Perault AI, Giacometti SI, Sommerfield AG, DuMont AL, Lacey KA, Zheng X, Sproch J, Petzold C, Dancel-Manning K, Gonzalez S, Annavajhala M, Beckford C, Zeitouni N, Liang FX, van Bakel H, Shopsin B, Uhlemann AC, Pironti A, Torres VJ. Capsular Polysaccharide Is Essential for the Virulence of the Antimicrobial-Resistant Pathogen Enterobacter hormaechei. mBio 2023; 14:e0259022. [PMID: 36779722 PMCID: PMC10127600 DOI: 10.1128/mbio.02590-22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2022] [Accepted: 01/13/2023] [Indexed: 02/14/2023] Open
Abstract
Nosocomial infections caused by multidrug-resistant (MDR) Enterobacter cloacae complex (ECC) pathogens are on the rise. However, the virulence strategies employed by these pathogens remain elusive. Here, we study the interaction of ECC clinical isolates with human serum to define how this pathogen evades the antimicrobial action of complement, one of the first lines of host-mediated immune defense. We identified a small number of serum-sensitive strains, including Enterobacter hormaechei strain NR3055, which we exploited for the in vitro selection of serum-resistant clones. Comparative genomics between the serum-sensitive NR3055 strain and the isolated serum-resistant clones revealed a premature stop codon in the wzy gene of the capsular polysaccharide biosynthesis locus of NR3055. The complementation of wzy conferred serum resistance to NR3055, prevented the deposition of complement proteins on the bacterial surface, inhibited phagocytosis by human neutrophils, and rendered the bacteria virulent in a mouse model of peritonitis. Mice exposed to a nonlethal dose of encapsulated NR3055 were protected from subsequent lethal infections by encapsulated NR3055, whereas mice that were previously exposed to unencapsulated NR3055 succumbed to infection. Thus, capsule is a key immune evasion determinant for E. hormaechei, and it is a potential target for prophylactics and therapeutics to combat these increasingly MDR human pathogens. IMPORTANCE Infections caused by antimicrobial resistant bacteria are of increasing concern, especially those due to carbapenem-resistant Enterobacteriaceae pathogens. Included in this group are species of the Enterobacter cloacae complex, regarding which there is a paucity of knowledge on the infection biology of the pathogens, despite their clinical relevance. In this study, we combine techniques in comparative genomics, bacterial genetics, and diverse models of infection to establish capsule as an important mechanism of Enterobacter pathogens to resist the antibacterial activity of serum, a first line of host defense against bacterial infections. We also show that immune memory targeting the Enterobacter capsule protects against lethal infection. The further characterization of Enterobacter infection biology and the immune response to infection are needed for the development of therapies and preventative interventions targeting these highly antibiotic resistant pathogens.
Collapse
Affiliation(s)
- Amelia St. John
- Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
- Antimicrobial-Resistant Pathogens Program, New York University Grossman School of Medicine, New York, New York, USA
| | - Andrew I. Perault
- Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
- Antimicrobial-Resistant Pathogens Program, New York University Grossman School of Medicine, New York, New York, USA
| | - Sabrina I. Giacometti
- Department of Cell Biology, New York University Grossman School of Medicine, New York, New York, USA
| | - Alexis G. Sommerfield
- Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
| | - Ashley L. DuMont
- Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
| | - Keenan A. Lacey
- Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
| | - Xuhui Zheng
- Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
| | - Julia Sproch
- Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
| | - Chris Petzold
- Microscopy Laboratory, Division of Advanced Research Technologies, New York University Langone Health, New York, New York, USA
| | - Kristen Dancel-Manning
- Microscopy Laboratory, Division of Advanced Research Technologies, New York University Langone Health, New York, New York, USA
| | - Sandra Gonzalez
- Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
| | - Medini Annavajhala
- Department of Medicine, Division of Infectious Diseases, Columbia University Medical Center, New York, New York, USA
| | - Colleen Beckford
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Nathalie Zeitouni
- Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Feng-Xia Liang
- Microscopy Laboratory, Division of Advanced Research Technologies, New York University Langone Health, New York, New York, USA
| | - Harm van Bakel
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA
- Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA
| | - Bo Shopsin
- Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
- Antimicrobial-Resistant Pathogens Program, New York University Grossman School of Medicine, New York, New York, USA
- Department of Medicine, Division of Infectious Diseases, New York University Grossman School of Medicine, New York, New York, USA
| | - Anne-Catrin Uhlemann
- Department of Medicine, Division of Infectious Diseases, Columbia University Medical Center, New York, New York, USA
| | - Alejandro Pironti
- Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
- Antimicrobial-Resistant Pathogens Program, New York University Grossman School of Medicine, New York, New York, USA
- Microbial Computational Genomic Core Lab, Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
| | - Victor J. Torres
- Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA
- Antimicrobial-Resistant Pathogens Program, New York University Grossman School of Medicine, New York, New York, USA
| |
Collapse
|
11
|
Casañas R, Castellvi P, Gil JJ, Torres-Torres M, Barón J, Teixidó M, Sampietro HM, Díez M, Fernández R, Sorli R, Siñol P, Jurado F, Carreras-Salvador R, Vazquez D, Gonzalez S, Martín MIFS, Raya-Tena A, Alvarez R, Amado-Rodriguez I, López LMM, Alonso J, Lalucat-Jo L. The effectiveness of a "EspaiJove.net"- a school-based intervention programme in increasing mental health knowledge, help seeking and reducing stigma attitudes in the adolescent population: a cluster randomised controlled trial. BMC Public Health 2022; 22:2425. [PMID: 36566192 PMCID: PMC9789578 DOI: 10.1186/s12889-022-14558-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2021] [Accepted: 11/07/2022] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND The aim of this study is to evaluate the short- and long-term effects of the universal mental health literacy intervention "EspaiJove.net" in increasing mental health knowledge, help seeking and reducing stigma attitudes in the adolescent population. We also examine whether these effects depend on the intervention intensity. METHODS: A clustered school-based randomised controlled trial (cRCT) design. SUBJECTS 1,298 secondary pupils aged 13 and 14 were recruited from 18 schools in Barcelona (Spain) between September 2016 and January 2018. INTERVENTION Three programmes were assessed: 1) Sensitivity Programme (SP; 1 h); 2) Mental Health Literacy (MHL; 6 h); 3) MHL plus a first-person Stigma Reduction Programme (MHL + SR; 7 h); 4) Control group (CG): waiting list. OUTCOME MEASURES 1) MHL: EspaiJove.net EMHL Test (First part and Second Part); 2) Stigma: RIBS and CAMI; 3) Help-seeking and use of treatment: GHSQ. ANALYSIS The data was collected at baseline, post-intervention and 6 and 12 months later. An intention-to-treat analysis and imputation method was used to analyse the missing data. Intervention effects were analysed using multilevel modelling. RESULTS One thousand thirty-two students were included (SP = 225; MHL = 261; MHL + SR = 295 and CG = 251). The MHL and MHL + SR interventions showed short- and long-term an increase in knowledge compared to SP and CG, but no significant change post-intervention or over time (First part p = 0.52 and Second part p = 0.62) between intervention groups and CG. No significant changes were found in stigma scores post-intervention or over time (CAMI p = 0.61 and RIBS p = 0.98) or in help-seeking scores (parent p = 0.69; teacher p = 0.23 and healthcare professional p = 0.75). The MHL + SR intervention was the best valued and recommended (p < 0.005). CONCLUSIONS The three interventions of the EspaiJove.net programme (SP, MHL and MHL + SR) seem not to be effective in terms MHL, Stigma and help-seeking behaviours. The contact with a person who has experimented mental illness first-hand did not reduce stigma attitudes. Further research should deal with the heterogeneity of MHL interventions (concept, duration and measures) and identify which components of stigma interventions are effective. TRIAL REGISTRATION ClinicalTrials.gov identifier: NCT03215654 (registration date 12 July 2017).
Collapse
Affiliation(s)
- Rocío Casañas
- grid.466539.b0000 0004 1777 1290Research Department, Associació Centre Higiene Mental Les Corts, C/ Numància, 103-105, Bajos, 08029 Barcelona, Spain
| | - Pere Castellvi
- grid.410675.10000 0001 2325 3084Department of Medicine, Universitat Internacional de Catalunya, Campus Sant Cugat. C/ Josep Trueta s/n, Sant Cugat del Vallés, 08195 Barcelona, Spain
| | - Juan-José Gil
- grid.466539.b0000 0004 1777 1290Child and Juvenile Mental Health Centre of Les Corts- Sarrià Sant Gervasi, Associació Centre Higiene Mental Les Corts, C/Montnegre 21, 3a Planta, 08029 Barcelona, Spain
| | - María Torres-Torres
- grid.466539.b0000 0004 1777 1290Child and Juvenile Mental Health Centre of Les Corts- Sarrià Sant Gervasi, Associació Centre Higiene Mental Les Corts, C/Montnegre 21, 3a Planta, 08029 Barcelona, Spain
| | - Jesica Barón
- grid.466539.b0000 0004 1777 1290Child and Juvenile Mental Health Centre of Les Corts- Sarrià Sant Gervasi, Associació Centre Higiene Mental Les Corts, C/Montnegre 21, 3a Planta, 08029 Barcelona, Spain
| | - Mercè Teixidó
- grid.466539.b0000 0004 1777 1290Mental Health Area of Les Corts- Sarrià Sant Gervasi, Associació Centre Higiene Mental Les Corts, C/Via Augusta 364-372, 4a Planta, 08017 Barcelona, Spain
| | | | - Marta Díez
- Activament Catalunya Associació, C/ Rocafort, 242 Bis, 3R B, 08029 Barcelona, Spain
| | - Raúl Fernández
- grid.418476.80000 0004 1767 8715Child and Juvenile Mental Health Centre of Ciutat Vella- Sant Martí, Instituto de Neuropsiquiatria y Adicciones del Parc de Salut del Mar (INAD), Consorci Parc de Salut Mar, C/ Ramon Turró, 337, 339, 08019 Barcelona, Spain
| | - Raquel Sorli
- grid.418476.80000 0004 1767 8715Child and Juvenile Mental Health Centre of Ciutat Vella- Sant Martí, Instituto de Neuropsiquiatria y Adicciones del Parc de Salut del Mar (INAD), Consorci Parc de Salut Mar, C/ Ramon Turró, 337, 339, 08019 Barcelona, Spain
| | - Patricia Siñol
- grid.418476.80000 0004 1767 8715Child and Juvenile Mental Health Centre of Ciutat Vella- Sant Martí, Instituto de Neuropsiquiatria y Adicciones del Parc de Salut del Mar (INAD), Consorci Parc de Salut Mar, C/ Ramon Turró, 337, 339, 08019 Barcelona, Spain
| | - Francisca Jurado
- grid.22061.370000 0000 9127 6969Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut (ICS), C/Balmes, 22, 08007 Barcelona, Spain
| | - Regina Carreras-Salvador
- grid.418476.80000 0004 1767 8715Instituto de Neuropsiquiatria y Adicciones del Parc de Salut del Mar (INAD), Consorci Parc de Salut Mar, Passeig Marítim, 25-29, 08003 Barcelona, Spain
| | - Davinia Vazquez
- grid.22061.370000 0000 9127 6969Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut (ICS), C/Balmes, 22, 08007 Barcelona, Spain
| | - Sandra Gonzalez
- grid.22061.370000 0000 9127 6969Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut (ICS), C/Balmes, 22, 08007 Barcelona, Spain
| | - Maria Isabel Fernandez-San Martín
- grid.22061.370000 0000 9127 6969Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut (ICS), C/Balmes, 22, 08007 Barcelona, Spain
| | - Antonia Raya-Tena
- grid.22061.370000 0000 9127 6969Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut (ICS), C/Balmes, 22, 08007 Barcelona, Spain
| | - Rosa Alvarez
- grid.22061.370000 0000 9127 6969Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut (ICS), C/Balmes, 22, 08007 Barcelona, Spain
| | - Isaac Amado-Rodriguez
- grid.22061.370000 0000 9127 6969Gerència d’Atenció Primària Barcelona Ciutat, Institut Català de la Salut (ICS), C/Balmes, 22, 08007 Barcelona, Spain
| | - Luis Miguel Martín- López
- grid.418476.80000 0004 1767 8715Instituto de Neuropsiquiatria y Adicciones del Parc de Salut del Mar (INAD), Consorci Parc de Salut Mar, Passeig Marítim, 25-29, 08003 Barcelona, Spain
| | - Jordi Alonso
- grid.466571.70000 0004 1756 6246Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), CIBERESP, C/ Dr. Aiguader, 88, 08003 Barcelona, Spain
| | - Lluís Lalucat-Jo
- grid.466539.b0000 0004 1777 1290Research Department, Associació Centre Higiene Mental Les Corts, C/ Numància, 103-105, Bajos, 08029 Barcelona, Spain
| |
Collapse
|
12
|
Migliore RA, Adaniya ME, Barranco MA, Gonzalez S, Dorsch J. Relationship between left ventriculoarterial coupling and damage stage in severe aortic stenosis. Eur Heart J 2022. [DOI: 10.1093/eurheartj/ehac544.1521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Background
In patients with severe aortic stenosis (AS), an anatomic and functional staging classification has been proposed to assess extent of cardiac chambers damage to improve the decision of aortic valve replacement based only in symptoms or ejection fraction (EF) <50%. This staging relies on the concept that left ventricular (LV) afterload secondary to AS induce LV dysfunction with progression to LV and right ventricular damage. However, afterload has valvular and vascular components, and the latter is not evaluated by the classification of stages. Characteristics of arterial vasculature can impact on LV function through the alteration in LV-VA coupling which is the relationship between effective arterial elastance (Ea) and LV end-systolic elastance (Emax).
Objective
To evaluate the relationship between LV-VA coupling and the different stages of cardiac damage in severe AS.
Methods
We studied 205 patients, age average 70±11 years, 117 men, with severe AS (AVA <1 cm2) with Doppler echocardiography. Measurements of cardiac chambers were made according to ASE/EACVI Guidelines. Ea was calculated as end-systolic pressure divided by stroke volume. End-systolic pressure was obtained from tonometry of carotid pulse. Emax was estimated by the method of Senzaki (1) as an index of LV contractility. Ea / Emax ratio was used to assess LV-VA coupling. Patients were divided in five groups according to the classification of staging cardiac damage proposed by Tasted (2): stage 0, no valvular cardiac damage; stage 1, LV damage (EF <60%); stage 2, left atrial or mitral valve damage; stage 3, pulmonary vasculature or tricuspid valve damage and stage 4, right ventricular damage, or subclinical heart failure (LV stroke volume index <30 ml/m2).
Results
Mean ± standard deviation (see Table 1). No patient was in stage 0. Symptoms was present in 40% of stage 1, 85% of stage 2 and 100% of stage 3 and 4. Ea increases from stage 2 to stage 4 while Emax did not change in those groups but decreased from stage 1 to 2. Consequently, LV-VA coupling progressively decreased from stage 1 to 4.
Conclusions
Worsening of LV-VA coupling increase with staging cardiac damage. The alteration of LV-VA coupling from stage 2 to 4 is due to an increase in Ea without significant changes in level of contractility (Emax). The progression of cardiac damage appears to be related not only to valve disease but also to the characteristics of arterial vasculature.
Funding Acknowledgement
Type of funding sources: None.
Collapse
Affiliation(s)
| | | | | | - S Gonzalez
- Hospital Eva Peron , San Martin , Argentina
| | - J Dorsch
- Hospital Eva Peron , San Martin , Argentina
| |
Collapse
|
13
|
Labonde A, Lades G, Debourdeau A, Ragi O, Lehmann L, Vitton V, Barthet M, Legros R, Albouys J, Geyl S, Loustaud-Ratti V, Monteil J, Gonzalez S, Gonzalez JM, Jacques J. Gastric peroral endoscopic myotomy in refractory gastroparesis: long-term outcomes and predictive score to improve patient selection. Gastrointest Endosc 2022; 96:500-508.e2. [PMID: 35413333 DOI: 10.1016/j.gie.2022.04.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/12/2021] [Accepted: 04/03/2022] [Indexed: 02/08/2023]
Abstract
BACKGROUND AND AIMS Limited data exist concerning the long-term efficiency of gastric peroral endoscopic myotomy (G-POEM) as a treatment of refractory gastroparesis. This study evaluated the 3-year results of G-POEM in patients with refractory gastroparesis. METHODS This was a prospective multicenter study of all G-POEM operations performed in 2 expert French centers for 46 patients with refractory gastroparesis with at least 3 years of follow-up. RESULTS Clinical success was 65.2% at 36 months. There was significant improvement in symptom severity. Median Gastroparesis Cardinal Symptom Index decreased from 3.33 to 1.80 (P < .0001), with improvement in all subscales. We created a predictive score concerning G-POEM success (G-POEM predictive score) to which points were assigned as follows: nausea subscale <2: predictive of success, 1 point; satiety subscale >4: predictive of success, 1 point; bloating subscale >3.5: predictive of success, 1 point; percentage of gastric retention at 4 hours on scintigraphy >50%: 1 point. A threshold of 2 was identified by receiver operating characteristic curve analysis with an area under the curve of .825 that predicted clinical success with a sensitivity of 93.3% (95% confidence interval [CI], .77-.99), specificity of 56.3% (95% CI, .33-.77), positive predictive value of 80% (95% CI, .67-.93), negative predictive value of 81.8% (95% CI, .59-1.00), and accuracy of 80.4% (95% CI, .69-.92). Patients with a score ≥2 were significantly more likely to be responders at 3 years than were patients with a score <2 (80% and 18%, respectively; P = .0004). CONCLUSIONS The clinical success of G-POEM for refractory gastroparesis was 65.2% at 36 months. Our predictive score offers an easy tool that needs to be confirmed in other studies.
Collapse
Affiliation(s)
- Amélie Labonde
- Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France
| | | | - Antoine Debourdeau
- Service d'Hépato-gastro-entérologie, CHU Montpellier, Montpellier, France
| | - Olivier Ragi
- Service d'Hépato-gastro-entérologie, CHU Lyon, Lyon, France
| | - Lauriane Lehmann
- Service d'Hépato-gastro-entérologie, Polyclinique de Limoges, Limoges, France
| | - Véronique Vitton
- Service d'Hépato-gastro-entérologie, APHM Hôpital Nord, Marseille, France
| | - Marc Barthet
- Service d'Hépato-gastro-entérologie, APHM Hôpital Nord, Marseille, France
| | - Romain Legros
- Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France
| | - Jérémie Albouys
- Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France
| | - Sophie Geyl
- Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France
| | | | - Jacques Monteil
- Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France
| | - Sandra Gonzalez
- Service de médecine nucléaire, APHM Hôpital Nord, Marseille, France
| | | | - Jérémie Jacques
- Service d'Hépato-gastro-entérologie, CHU Limoges, Limoges, France.
| |
Collapse
|
14
|
Sahu A, Kraehenbuehl L, Holland A, Cordova M, Gill M, Alessi-Fox C, Gonzalez S, Kurtansky N, Rossi A, Marghoob A, Guitera P, Pulitzer M, Jason Chen C, Merghoub T, Rajadhyaksha M. 834 In vivo phenotyping of the tumor-immune microenvironment in skin cancers. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.848] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
15
|
Mejia MC, Zoorob R, Gonzalez S, Mosqueda M, Levine R. Key Informants' Perspectives on Implementing a Comprehensive Lung Cancer Screening Program in a Safety Net Healthcare System: Leadership, Successes, and Barriers. J Cancer Educ 2022; 37:1144-1151. [PMID: 33417096 DOI: 10.1007/s13187-020-01931-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 11/24/2020] [Indexed: 06/12/2023]
Abstract
Implementing evidence-based practice (EBP) in a safety net healthcare system is challenging. This study examined factors associated with feasibility and potential facilitators and barriers which might affect the implementation of a new evidence-based comprehensive primary care and community health-based program aiming to promote efficient and equitable delivery of Lung Cancer Screening and Tobacco Cessation (LCS-TC). Fifty-three key informants were interviewed. Informants discussed their perceptions of adoption of screening and appropriate referral practices across 15 community health centers. They also identified barriers and facilitators to implementing the LCS-TC program. Interview data were analyzed using inductive thematic analysis. Three major themes representing facilitators and barriers were identified: (1) Allocation of resources and services coverage; (2) need for a collaborative process to engage stakeholders and identify champions; and (3) stakeholders need different types of evidence to support implementation. The top three activities identified as essential for success included provision of sufficient resources for radiologic screening (30%); using non-physician staff for screening (30%); and minimizing the time healthcare providers need to contribute (23%). Conversely, the top three barriers were lack of resources for screening and treatment (60%); insufficient time to address complex patient problems (36%); and perceived lack of patient buy-in (30%). Models for EBP implementation provide stepwise guidance; however, particular contextual factors act as facilitators or barriers to the process. Findings inform EBP implementation efforts regarding resources and key barriers to success around organizational-level supports and promotion of suitable EBP programs.
Collapse
Affiliation(s)
- Maria C Mejia
- Department of Family and Community Medicine, Baylor College of Medicine, 3701 Kirby Dr., Suite 600, Houston, TX, 77098, USA.
| | - Roger Zoorob
- Department of Family and Community Medicine, Baylor College of Medicine, 3701 Kirby Dr., Suite 600, Houston, TX, 77098, USA
| | - Sandra Gonzalez
- Department of Family and Community Medicine, Baylor College of Medicine, 3701 Kirby Dr., Suite 600, Houston, TX, 77098, USA
| | - Maribel Mosqueda
- Department of Family and Community Medicine, Baylor College of Medicine, 3701 Kirby Dr., Suite 600, Houston, TX, 77098, USA
| | - Robert Levine
- Department of Family and Community Medicine, Baylor College of Medicine, 3701 Kirby Dr., Suite 600, Houston, TX, 77098, USA
| |
Collapse
|
16
|
Puig-Vallverdú J, Romaguera D, Fernández-Barrés S, Gignac F, Ibarluzea J, Santa-Maria L, Llop S, Gonzalez S, Vioque J, Riaño-Galán I, Fernández-Tardón G, Pinar A, Turner MC, Arija V, Salas-Savadó J, Vrijheid M, Julvez J. The association between maternal ultra-processed food consumption during pregnancy and child neuropsychological development: A population-based birth cohort study. Clin Nutr 2022; 41:2275-2283. [PMID: 36087519 DOI: 10.1016/j.clnu.2022.08.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2022] [Revised: 08/01/2022] [Accepted: 08/03/2022] [Indexed: 11/03/2022]
|
17
|
Saknite I, Gill M, Alessi-Fox C, Zwerner J, Lehman J, Shinohara M, Novoa R, Chen H, Byrne M, Gonzalez S, Ardigo M, Tkaczyk E. 806 Histopathology features of cutaneous acute graft-versus-host disease can be reliably detected by noninvasive reflectance confocal microscopy. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.05.820] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
18
|
Mitchell RA, Altszuler R, Gonzalez S, Johnson R, Frevert U, Nardin E. Innate Immune Responses and P. falciparum CS Repeat-Specific Neutralizing Antibodies Following Vaccination by Skin Scarification. Front Immunol 2022; 13:801111. [PMID: 35734173 PMCID: PMC9207416 DOI: 10.3389/fimmu.2022.801111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2021] [Accepted: 05/09/2022] [Indexed: 11/17/2022] Open
Abstract
The skin is the site of host invasion by the mosquito-borne Plasmodium parasite, which caused an estimated 229 million infections and 409,000 deaths in 2019 according to WHO World Malaria report 2020. In our previous studies, we have shown that skin scarification (SS) with a P. falciparum circumsporozoite (CS) peptide in the oil-in-water adjuvant AddaVax containing a combination of TLR 7/8 and TLR 9 agonists can elicit sporozoite neutralizing antibodies. SS with AddaVax + TLR agonists, but not AddaVax alone, elicited CD4+ Th1 cells and IgG2a/c anti-repeat antibody. To explore the innate immune responses that may contribute to development of adaptive immunity following SS, we examined the skin at 4h and 24h post priming with CS peptide in AddaVax with or without TLR agonists. H&E stained and IHC-labeled dorsal skin sections obtained 24h post SS demonstrated a marked difference in the pattern of infiltration with F4/80+, CD11b+ and Ly6G+ cells at the immunization site, with the lowest intensity noted following SS with AddaVax + TLR agonists. Serum collected at 4h post SS, had reproducible increases in IL-6, MIP-3α, IL-22 and IP-10 (CXCL10) following SS with AddaVax + TLR agonists, but not with AddaVax alone. To begin to decipher the complex roles of these pro-inflammatory cytokines/chemokines, we utilized IP-10 deficient (IP-10 -/-) mice to examine the role of this chemokine in the development of anti-repeat antibody response following SS. In the absence of IP-10, the levels of Th1-type IgG2a/c antibody and kinetics of the primary anti-repeat antibody response were reduced following prime and boost. The IP-10 chemokine, present as early as 4h post prime, may provide an early serological marker for rapid screening of adjuvant formulations and delivery platforms to optimize SS-induced humoral immunity to CS repeats as well as other pathogens.
Collapse
|
19
|
Mota S, Bensalel J, Park DH, Gonzalez S, Rodriguez A, Gallego-Delgado J. Treatment Reducing Endothelial Activation Protects against Experimental Cerebral Malaria. Pathogens 2022; 11:pathogens11060643. [PMID: 35745497 PMCID: PMC9229727 DOI: 10.3390/pathogens11060643] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2022] [Revised: 05/25/2022] [Accepted: 05/30/2022] [Indexed: 11/30/2022] Open
Abstract
Cerebral malaria (CM) is the most severe neurological complication of malaria caused by Plasmodium falciparum infection. The available antimalarial drugs are effective at clearing the parasite, but the mortality rate remains as high as 20% of CM cases. At the vascular level, CM is characterized by endothelial activation and dysfunction. Several biomarkers of endothelial activation have been associated with CM severity and mortality, making the brain vascular endothelium a potential target for adjunctive therapies. Statins and Angiotensin II Receptor Blockers (ARBs) are drugs used to treat hypercholesterolemia and hypertension, respectively, that have shown endothelial protective activity in other diseases. Here, we used a combination of a statin (atorvastatin) and an ARB (irbesartan) as adjunctive therapy to conventional antimalarial drugs in a mouse experimental model of CM. We observed that administration of atorvastatin–irbesartan combination decreased the levels of biomarkers of endothelial activation, such as the von Willebrand factor and angiopoietin-1. After mice developed neurological signs of CM, treatment with the combination plus conventional antimalarial drugs increased survival rates of animals 3–4 times compared to treatment with antimalarial drugs alone, with animals presenting lower numbers and smaller hemorrhages in the brain. Taken together, our results support the hypothesis that inhibiting endothelial activation would greatly reduce the CM-associated pathology and mortality.
Collapse
Affiliation(s)
- Sabrina Mota
- Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA; (S.M.); (D.H.P.); (S.G.)
| | - Johanna Bensalel
- Department of Biological Sciences, Lehman College, The City University of New York, Bronx, New York, NY 10468, USA;
- Ph.D. Program in Biology, The Graduate Center, The City University of New York, New York, NY 10016, USA
| | - Do Hee Park
- Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA; (S.M.); (D.H.P.); (S.G.)
| | - Sandra Gonzalez
- Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA; (S.M.); (D.H.P.); (S.G.)
| | - Ana Rodriguez
- Department of Microbiology, New York University School of Medicine, New York, NY 10016, USA; (S.M.); (D.H.P.); (S.G.)
- Correspondence: (A.R.); (J.G.-D.); Tel.: +1-347-577-4109 (A.R. & J.G.-D.)
| | - Julio Gallego-Delgado
- Department of Biological Sciences, Lehman College, The City University of New York, Bronx, New York, NY 10468, USA;
- Ph.D. Program in Biology, The Graduate Center, The City University of New York, New York, NY 10016, USA
- Correspondence: (A.R.); (J.G.-D.); Tel.: +1-347-577-4109 (A.R. & J.G.-D.)
| |
Collapse
|
20
|
Saknite I, Gill M, Alessi-Fox C, Zwerner JP, Lehman JS, Shinohara MM, Novoa RA, Chen H, Byrne M, Gonzalez S, Ardigo M, Tkaczyk ER. In Vivo Reflectance Confocal Microscopy of Cutaneous Acute Graft-Versus-Host Disease: Concordance with Histopathology and Interobserver Reproducibility of a Glossary with Representative Images. J Eur Acad Dermatol Venereol 2022; 36:1034-1044. [PMID: 35175678 DOI: 10.1111/jdv.18004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2021] [Accepted: 01/18/2022] [Indexed: 11/30/2022]
Abstract
BACKGROUND The reliability to noninvasively identify features of inflammatory dermatoses by reflectance confocal microscopy (RCM) remains unknown. Lack of formal training among RCM readers can result in inconsistent assessments, limiting clinical utility. Specific consensus terminology with representative images is necessary to ensure consistent feature-level interpretation among RCM readers. OBJECTIVES (1) Develop a glossary with representative images of RCM features of cutaneous acute graft-versus-host disease (aGVHD) for consistent interpretation among observers, (2) assess the interobserver reproducibility among RCM readers using the glossary, and (3) determine the concordance between RCM and histopathology for aGVHD features. METHODS Through an iterative process of refinement and discussion among five international RCM experts, we developed a glossary with representative images of RCM features of aGVHD. From April to November 2018, patients suspected of aGVHD were imaged with RCM and subsequently biopsied. 17 lesions from 12 patients had clinically and pathologically confirmed cutaneous aGVHD. For each of these lesions, four dermatopathologists and four RCM readers independently evaluated the presence of aGVHD features in scanned histopathology slides and 1.5x1.5 mm RCM submosaics at 4 depths (blockstacks), respectively. RCM cases were adjudicated by a fifth RCM expert. Interobserver reproducibility was calculated by U statistic. Concordance between modalities was determined by fraction agreement. RESULTS We present a glossary with representative images of 18 aGVHD features by RCM. The average interobserver reproducibility among RCM readers (75%, confidence interval, CI: 71%-79%) did not differ significantly from dermatopathologists (80%, 76%-85%). The concordance between RCM and histopathology was 59%. CONCLUSIONS By using the glossary, the interobserver reproducibility among RCM readers was similar to the interobserver reproducibility among dermatopathologists. There was good concordance between RCM and histopathology to visualize aGVHD features. The implementation of RCM can now be advanced in a variety of inflammatory conditions with a validated glossary and representative image set.
Collapse
Affiliation(s)
- I Saknite
- Department of Dermatology, Vanderbilt University Medical Center, 719 Thompson Lane, One Hundred Oaks Suite 26300, Nashville, TN, 37204, USA.,Biophotonics Laboratory, Institute of Atomic Physics and Spectroscopy, University of Latvia, Jelgava Str 3 - #605, Riga, LV1004, Latvia
| | - M Gill
- SkinMedical Research and Diagnostics, PLLC, 64 Southlawn Ave, Dobbs Ferry, NY, 10522, USA.,Department of Pathology, SUNY Downstate Health Sciences University, 450 Clarkson Avenue, Brooklyn, NY, 11203, USA.,Medicine and Medical Specialties Department, Alcalá University, 28871, Alcalá de Henares, Madrid, Spain
| | - C Alessi-Fox
- Clinical Development, Caliber Imaging and Diagnostics Inc, 50 Methodist Hill Drive, Suite 1000, Rochester, NY, 14623, USA
| | - J P Zwerner
- Department of Dermatology, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA
| | - J S Lehman
- Division of Dermatology, Department of Medicine, Department of Laboratory Medicine and Pathology, University of Washington, Box 356524, Seattle, WA, 98195, USA
| | - M M Shinohara
- Department of Dermatology, Department of Pathology, Stanford University, 300 Pasteur Dr Rm H1507, MC 5627, Stanford, CA, 94305, USA
| | - R A Novoa
- Department of Biostatistics, Vanderbilt University Medical Center, 1301 Medical Center Dr Suite 3903, Nashville, TN, 37232, USA
| | - H Chen
- Department of Biostatistics, Vanderbilt University Medical Center, 1301 Medical Center Dr Suite 3903, Nashville, TN, 37232, USA.,Vanderbilt-Ingram Cancer Center, 1301 Medical Center Dr #1710, Nashville, TN, 37232, USA
| | - M Byrne
- Vanderbilt-Ingram Cancer Center, 1301 Medical Center Dr #1710, Nashville, TN, 37232, USA
| | - S Gonzalez
- Medicine and Medical Specialties Department, Alcalá University, 28871, Alcalá de Henares, Madrid, Spain
| | - M Ardigo
- San Gallicano Dermatological Institute - IRCCS, Via Elio Chianesi 53, 00144, Rome, Italy
| | - E R Tkaczyk
- Department of Dermatology, Vanderbilt University Medical Center, 719 Thompson Lane, One Hundred Oaks Suite 26300, Nashville, TN, 37204, USA.,Vanderbilt-Ingram Cancer Center, 1301 Medical Center Dr #1710, Nashville, TN, 37232, USA.,Dermatology Service and Research Service, Tennessee Valley Healthcare System, Department of Veterans Affairs, 1310 24th Avenue South, Nashville, TN, 37212, USA
| |
Collapse
|
21
|
Hirth JM, Valadez C, Gonzalez S, Kowalchuk A, Gutierrez JA, Zoorob R. Racial/ethnic variations in alcohol and cigarette use by pregnancy status among 20- to 44-year-old women, NHANES 2001–2018. Womens Health (Lond Engl) 2022; 18:17455057221112188. [PMID: 35819070 PMCID: PMC9280819 DOI: 10.1177/17455057221112188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Objectives: This study examines alcohol consumption and smoking behaviors by pregnancy status and race/ethnicity in order to inform improved interventions designed to assist women of all races to avoid alcohol and tobacco use during pregnancy for their health and to prevent potential fetal exposure. Methods: This retrospective secondary data analysis utilized nationally representative National Health and Nutrition Examination Survey data between 2001 and 2018. Smoking and alcohol use were evaluated by race/ethnicity and pregnancy risk. Sexual behavior, reproductive health, and prescription drug use determined pregnancy risk, categorized as low pregnancy risk, at risk of becoming pregnant, and pregnant. Binary and multinomial multivariable logistic regression were used to examine associations. Results: The final sample consisted of 10,019 women of which 11.8% were Mexican American, 7.7% other Hispanic, 65.5% white, and 15% black (weighted percentages). White low pregnancy risk and pregnancy risk smoked most frequently in respective pregnancy risk groups (p < 0.001). Among pregnant women, smoking prevalence was highest among black women (14.0%, p < 0.01). Pregnancy risk women were more likely to smoke and pregnant women were less likely to smoke compared with low pregnancy risk. Low pregnancy risk and pregnancy risk Hispanics had a lower prevalence of binge drinking, but prevalence decreased less among pregnant Hispanics than other racial/ethnic groups. In adjusted analyses, pregnancy risk black women had more than 2 times the odds of combined smoking and alcohol consumption compared with low pregnancy risk black women. Conclusion: Women who may become pregnant need interventions and improved policy to prevent alcohol use and smoking. Culturally appropriate alcohol and smoking cessation interventions before pregnancy and improved contraception access are needed.
Collapse
Affiliation(s)
- Jacqueline M Hirth
- Department of Family and Community Health, Baylor College of Medicine, Houston, TX, USA
| | | | - Sandra Gonzalez
- Department of Family and Community Health, Baylor College of Medicine, Houston, TX, USA
| | - Alicia Kowalchuk
- Department of Family and Community Health, Baylor College of Medicine, Houston, TX, USA
| | - Judith A Gutierrez
- Department of Family and Community Health, Baylor College of Medicine, Houston, TX, USA
| | - Roger Zoorob
- Department of Family and Community Health, Baylor College of Medicine, Houston, TX, USA
| |
Collapse
|
22
|
Viguera L, Blasi A, Reverter E, Arjona B, Caballero M, Chocron I, García-López JA, Gutierrez R, Martin MJ, Pérez-Peña J, Pitera J, Zarragoikoetxea I, Sabaté A, Belmonte C, Bustamante J, Beltran J, Colmenero J, Costa M, Fondevila C, Galan P, García-Palenciano C, Garrido JL, Gomez-Serrano J, Gonzalez S, de la Fuente JC, Jimeno C, Leon A, Lopez-Toribio P, Marín A, Del Mazo A, de Nadal M, Ojinaga G, Padilla J, Tevar J, Torres M, Zaballos M. Liver transplant with controlled donors after circulatory death with normothermic regional perfusion and brain dead donors: A multicenter cohort study of transfusion, one-year graft survival and mortality. Int J Surg 2021; 96:106169. [PMID: 34848373 DOI: 10.1016/j.ijsu.2021.106169] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2021] [Revised: 09/14/2021] [Accepted: 11/02/2021] [Indexed: 01/18/2023]
Abstract
BACKGROUND Controlled donation after circulatory death (cDCD) has expanded the donor pool for liver transplantation (LT). However, transfusion requirements and perioperative outcomes should be elucidated. The aim of this multicenter study was to assess red blood cell (RBC) transfusions, one-year graft and patient survival after LT after cDCD with normothermic regional perfusion (NRP) compared with donors after brain death (DBD). METHODS 591 LT carried out in ten centers during 2019 were reviewed. Thromboelastometry was used to manage coagulation and blood product transfusion in all centers. Normothermic regional perfusion was the standard technique for organ recovery. RESULTS 447 patients received DBD and 144 cDCD with NRP. Baseline MCF Extem was lower in the cDCD group There were no differences in the percentage of patients (63% vs. 61% p = 0.69), nor in the number of RBC units transfused (4.7 (0.2) vs 5.5 (0.4) in DBD vs cDCD, p = 0.11. Twenty-six patients (6%) died during admission for LT in the DBD group compared with 3 patients (2%) in the cDCD group (p = 0.15). To overcome the bias due to a worse coagulation profile in cDCD recipients, matched samples were compared. No differences in baseline laboratory data, or in intraoperative use of RBC or one-year outcome data were observed between DBD and cDCD recipients. CONCLUSIONS cDCD with NRP is not associated with increased RBC transfusion. No differences in graft and patient survival between cDCD and DBD were found. Donors after controlled circulatory death with NRP can increasingly be utilized with safety, improving the imbalance between organ donors and the ever-growing demand.
Collapse
Affiliation(s)
- Laura Viguera
- Anaesthesia Department, Hospital Clinic de Barcelona, IDIBAPS, Spain Anaesthesia Department, Hospital Reina Sofia, Spain Anaesthesia Department, Hospital Vall d'Hebron, Spain Anaesthesia Department, Hospital Clínico Universitario Virgen de la Arrixaca, Spain Anaesthesia Department, Hospital de Cruces, Spain Anaesthesia Department, Hospital Universitario de Badajoz, Spain Anaesthesia Department, Hospital Universitario de la Fe, Spain Anaesthesia Department, Hospital Universiari Bellvitge, Spain Hepatology Department, Hospital Clinic Barcelona, IDIBAPS, Spain Anaesthesia Department, Hospital Universitario Gregorio Marañon de Madrid, Spain Surgery Department, Hospital Clinic de Barcelona, IDIBAPS, Spain Anaesthesia Department, Hospital Universitari Bellvitge, Spain Hepatology Department, Hospital Clinic Barcelona, Spain Anaesthesia Department, Complejo Hospitalario Universitario A Coruña, Spain Anaesthesia Department, Hospital Universitario Gregorio Marañón Madrid, Spain Anaesthesia Department, Hospital Universitari Bellvitge, University of Barcelona, IDIBELL, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Walia N, Gonzalez S, Zoorob R. A Systematic Review of the Use of St. John's Wort for Smoking Cessation in Adults. Cureus 2021; 13:e18769. [PMID: 34796061 PMCID: PMC8590314 DOI: 10.7759/cureus.18769] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/14/2021] [Indexed: 11/10/2022] Open
Abstract
St. John’s wort (SJW) has been researched and clinically used for treating various psychiatric disorders, including depression. Few clinical trials have studied its use in smoking cessation. This systematic review provides comprehensive evidence of the studies conducted to date. Five databases were searched for randomized controlled trials (RCTs) that evaluated the effectiveness of SJW for smoking cessation in adults. The trials included the use of SJW alone, or along with nicotine replacement therapy, chromium, or behavioral therapies. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were used to report this systematic review. Overall, four RCTs met the eligibility criteria, and the risk of bias analysis was conducted using the Cochrane criteria. Abstinence, along with other physical symptoms, were measured as outcomes at the end of the follow-up period. Studies reported variable abstinence rates and a decrease in cravings at the end of 12-14 weeks. However, there was minimal to no difference reported between the intervention and placebo groups in all of the clinical trials. One of the studies reported minimal physical side effects. Overall, SJW was well tolerated. Quality analysis of the included studies showed low concerns in two studies while the other two studies showed high concerns in the risk of bias judgment. More clinical trials with larger sample sizes should be conducted in the future to evaluate the effectiveness of the use of SJW for smoking cessation.
Collapse
Affiliation(s)
- Namrata Walia
- Family and Community Medicine, Baylor College of Medicine, Houston, USA
| | - Sandra Gonzalez
- Family and Community Medicine, Baylor College of Medicine, Houston, USA
| | - Roger Zoorob
- Family and Community Medicine, Baylor College of Medicine, Houston, USA
| |
Collapse
|
24
|
Claire Ellis M, Gonzalez S, Winstead-Derlega C, Freiberger J, Kuchibhatla M, Luedke M, Posada-Quintero H, Chon K, D'Agostino D, Derrick B. 78 Physiologic Monitoring for Central Nervous System Oxygen Toxicity in Working Divers. Ann Emerg Med 2021. [DOI: 10.1016/j.annemergmed.2021.09.087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
25
|
Zapatero A, Roch M, Castro Tejero P, Büchser D, Martin de Vidales C, Gonzalez S, Rodríguez Carnero P, Murillo M. PD-0807 MRI-Guided focal boost to intraprostatic lesion using VMAT in prostate cancer. A Phase II Trial. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07086-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
26
|
Pieruzzini R, Ayala-Grosso C, de Jesus Navas J, Rodriguez W, Parra N, Luque E, Sanchez-Gago A, Gonzalez S, Hagobian A, Grullon A, Diaz K, Morales M, De Jesus M, Pena S, Rodriguez L, Pena L, Asaro A, Magris M. What smell and taste disorders by SARS-CoV-2 do we know? Predictive value of the Venezuelan Olfactory Test and RT-PCR molecular analysis in COVID-19 infection. RHINOL 2021. [DOI: 10.4193/rhinol/21.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Background: Smell and taste disorders are reported very frequently and at an early stage in SARS-CoV-2 infectious disease. These symptoms could be sensitive and specific to establish possible severity of the infection, and may suggest the flow of decisions as to further therapy. Objective: We asked whether smell and taste impairment are earlier and more sensitive symptoms than the RT-PCR molecular assays for SARS-CoV-2 detection. Methods: Subjects (N=275) with a probable COVID-19 diagnosis were classified as follows: Symptomatic with chemosensory dysfunction, symptomatic without chemosensory dysfunction, and asymptomatic. Validated unbiased testing of the chemosensory dysfunction was performed by means of the Venezuelan Olfactory Test and taste test. Nasal swabs and blood samples were analyzed by RT-PCR molecular analysis a rapid diagnostic test to detect the SARS-CoV-2 virus and viral antibodies, respectively. Smell and taste testing and RT-PCR were performed every 3 to 5 days to patients until full recovery. Results: Out of 144 patients that were positive for SARS-CoV-2: 45.83% had COVID-19 symptoms, smell and taste disorders; 23.61% had COVID-19 symptoms but not smell or taste disorders, and 30.55% were asymptomatic. Mild hyposmia and hypogeusia were frequently associated with SARS-CoV-2 symptoms. Recovery from chemosensory dysfunction occurred between day 3 and 14. RT-PCR becomes negative after 21 days. The Venezuelan Olfactory Test and taste test has a 61.68% positive predictive value, 45.83% sensitivity, and 68.7% specificity for SARS-CoV-2. Conclusions: Smell and taste disorders are associated symptoms with SARS-CoV-2 infection, but not a predictor of the disease, as compared to the molecular RT-PCR test.
Collapse
|
27
|
Franch‐Sarto M, Garcia‐Calduch O, Rivas A, Lopez A, Gonzalez‐Barca E, Sureda A, Baile M, Martin A, Salar A, Gutierrez A, Bastos M, Rodriguez M, Gonzalez S, Queizán J, Cordoba R, Montalbán C, Luzardo HD, Abrisqueta P, Garcia D, Hong A, Peñalver F, Moreno M, Sancho J. CENTRAL NERVOUS SYSTEM RELAPSE IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA TREATED WITH R‐CHOP: STUDY OF THE SPANISH LYMPHOMA GROUP GELTAMO. Hematol Oncol 2021. [DOI: 10.1002/hon.91_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- M. Franch‐Sarto
- Hospital Universitari Germans Trias i Pujol Hematology Badalona Spain
| | - O. Garcia‐Calduch
- Hospital Universitari Germans Trias i Pujol Hematology Badalona Spain
| | - A. Rivas
- Hospital Universitari Clinic Hematology Barcelona Spain
| | - A. Lopez
- Hospital Universitari Clinic Hematology Barcelona Spain
| | | | - A. Sureda
- Hospital Duran i Reynalds Hematology Bellvitge Spain
| | - M. Baile
- Hospital Universitario de Salamanca and IBSAL. Hematology Salamanca Spain
| | - A. Martin
- Hospital Universitario de Salamanca and IBSAL. Hematology Salamanca Spain
| | - A. Salar
- Hospital del Mar Hematology Barcelona Spain
| | | | - M. Bastos
- Hospital Universitario Gregorio Marañón Hematology Madrid Spain
| | - M.‐J. Rodriguez
- Hospital Universitario de Canarias Hematology Canarias Spain
| | - S. Gonzalez
- Hospital Universitario Marqués de Valdecilla Hematology Santander Spain
| | - J.‐A. Queizán
- Hospital General de Segovia Hematology Segovia Spain
| | - R. Cordoba
- Fundación Jiméndez Díaz Hematology Madrid Spain
| | - C. Montalbán
- MD Anderson Cancer Center Hematology Madrid Spain
| | - H. D. Luzardo
- Hospital Universitario de Gran Canarias Dr Negrín Hematology Las Palmas de Gran Canaria Spain
| | - P. Abrisqueta
- Hospital Universitari Vall d'Hebron Hematology Barcelona Spain
| | - D. Garcia
- Hospital La Zarzuela Hematology Madrid Spain
| | - A. Hong
- Hospital de Lanzarote Hematology Lanzarote Spain
| | | | - M. Moreno
- Hospital Universitari Germans Trias i Pujol Hematology Badalona Spain
| | - J.‐M. Sancho
- Hospital Universitari Germans Trias i Pujol Hematology Badalona Spain
| |
Collapse
|
28
|
Gill M, Pellacani G, Grant-Kels JM, Ardigò M, Chen CSJ, Gonzalez S, Guitera P, Longo C, Malvehy J, Markowitz O, Puig S, Rabinovitz H, Rao BK, Scope A, Ulrich M. Lost in translation: true clinical impact of reflectance confocal microscopy overlooked in 'Biopsy outperforms reflectance confocal microscopy in diagnosing and subtyping basal cell carcinoma: results and experiences from a randomized controlled multicentre trial'. Br J Dermatol 2020; 184:775-776. [PMID: 33090465 DOI: 10.1111/bjd.19602] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2020] [Accepted: 10/11/2020] [Indexed: 01/12/2023]
Affiliation(s)
- M Gill
- Department of Pathology, SUNY Downstate Medical Center, Brooklyn, NY, USA.,SkinMedical Research and Diagnostics, P.L.L.C., Dobbs Ferry, NY, USA.,Faculty of Medicine and Health Sciences, University of Alcala de Henares, Madrid, Spain
| | - G Pellacani
- Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy
| | - J M Grant-Kels
- Department of Dermatology, University of Connecticut Health Center, Farmington, CT, USA.,Department of Dermatology, University of Florida, Gainesville, FL, USA
| | - M Ardigò
- San Gallicano Institute IRCCS, Rome, Italy
| | - C-S J Chen
- Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - S Gonzalez
- Faculty of Medicine and Health Sciences, University of Alcala de Henares, Madrid, Spain
| | - P Guitera
- Sydney Melanoma Diagnostics Centre, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.,Discipline of Dermatology, Sydney Medical School, The University of Sydney, Sydney, Australia.,Melanoma Institute Australia, Sydney, NSW, Australia
| | - C Longo
- Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy.,Centro Oncologico ad Alta Tecnologia Diagnostica, Azienda Unità Sanitaria Locale-Istituto di Ricovero e Cura a Carattere Scientifico di Reggio Emilia, Reggio Emilia, Italy
| | - J Malvehy
- Melanoma Unit, Department of Dermatology, Hospital Clinic, Universitat de Barcelona, Institut d'investigacions biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - O Markowitz
- Icahn School of Medicine, Kimberly and Eric J. Waldman Department of Dermatology, Mount Sinai Hospital System, New York, NY, USA
| | - S Puig
- Melanoma Unit, Department of Dermatology, Hospital Clinic, Universitat de Barcelona, Institut d'investigacions biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.,Centro de Investigación Biomédica en Red de Enfermedades Raras, Barcelona, Spain
| | | | - B K Rao
- Departments of Dermatology and Pathology, Rutgers Robert Wood Johnson Medical School, Somerset, NJ, USA.,Department of Dermatology, Weill Cornell Medicine, New York, NY, USA
| | - A Scope
- The Kittner Skin Cancer Screening & Research Institute, Sheba Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
| | - M Ulrich
- CMB Collegium Medicum Berlin, Berlin, Germany
| |
Collapse
|
29
|
Migliore R, Adaniya M, Barranco M, Gonzalez S, Miramont G. Ejection dynamics and valve kinetics in patients with low-gradient severe aortic stenosis with preserved ejection fraction. Comparison between normal and low-flow. Eur Heart J 2020. [DOI: 10.1093/ehjci/ehaa946.1865] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background
Studies of ejection dynamics in severe aortic stenosis and prosthetic valve obstruction had demonstrated a delay in aortic valve opening.
Purpose
The aim of this study was to compare and evaluate ejection dynamics and valve kinetics in patients with severe aortic stenosis with preserved ejection fraction with normal and low flow.
Methods
83 patients (age average 68±11 years) with severe aortic stenosis (aortic valve area <1cm2) and preserved ejection fraction (≥50%) were studied with Doppler echocardiography and included prospectively. The ratio of aortic valve area measured at mid-deceleration and mid-acceleration (Md/Ma) were calculated using velocity of left ventricular outflow tract and aortic transvalvular velocity in continuity equation as an index of valvular kinetics. A ratio of Md/Ma >1 indicate delay in opening of aortic valve. Assessment of ejection dynamics was evaluated with acceleration time (AT), ejection time (ET) and the ratio AT/ET estimated from aortic Doppler velocities profiles. Aortic flow was calculated as stroke volume/ET. According to stroke volume index and mean gradient patients were classified in 3 groups: normal-flow, low-gradient (NFLG) 25 patients, low-flow, low-gradient (LFLG) 28 patients and normal-flow, high-gradient (HG) 30 patients. Analysis of the variance and coefficient of correlation “r” were used for statistical evaluation. A p value <0.05 was considered significant.
Results
There was no significant difference among the 3 groups with regard to ratio Md/Ma: NFLG 1.29±0.38, LFLG 1.22±0.26 and HG 1.23±0.45, NS. No difference was found in AT in the 3 groups, but ET was shorter in LFLG (310±30 ms) in comparison with NFLG (345±32 ms) and HG (361±31 ms), p<0.01. Ratio AT/ET occurred in early systole in NFLG (0.27±0.07) compared with LFLG (0.32±0.07) and HG (0.39±0.07), p<0.01. As expected, flow was decreased in LFLG (163±20 ml/s, p<0.001) compared with NFLG (217±13 ml/s) and HG (233±44 ml/s). There was no correlation among AT/ET and aortic flow or stroke volume index.
Conclusions
There were not differences among the groups with regard to kinetic of the valve evaluated by mean of ratio Md/Ma. According to ratio AT/ET, aortic valve takes less time to open in NFLG compared with LFLG and HG independent of aortic flow suggesting a different ejection dynamics pattern in this group.
Funding Acknowledgement
Type of funding source: None
Collapse
Affiliation(s)
- R Migliore
- Eva Peron Hospital, San Martin - Buenos Aires, Argentina
| | - M.E Adaniya
- Eva Peron Hospital, San Martin - Buenos Aires, Argentina
| | - M.A Barranco
- Eva Peron Hospital, San Martin - Buenos Aires, Argentina
| | - S Gonzalez
- Eva Peron Hospital, San Martin - Buenos Aires, Argentina
| | - G Miramont
- Eva Peron Hospital, San Martin - Buenos Aires, Argentina
| |
Collapse
|
30
|
Hansen MA, Modak S, McMaster S, Zoorob R, Gonzalez S. Implementing peer recovery coaching and improving outcomes for substance use disorders in underserved communities. J Ethn Subst Abuse 2020; 21:1029-1042. [PMID: 32969329 DOI: 10.1080/15332640.2020.1824839] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
INTRODUCTION The Peer Recovery Expansion Project (PREP) was designed to expand outreach and deliver enhanced treatment services via peer-recovery coaches for individuals with substance use disorder (SUD) and limited access to healthcare. METHODS PREP was implemented in low-socioeconomic areas with historic challenges to accessing SUD treatment. Services were provided to 153 clients through tailored cultural responsiveness, use of peer-based recovery coaching, and development of a Recovery Support Network. Outcome data were collected using the Government Performance and Reporting Act tool at intake and at 6-month follow-up for coaches and clients. RESULTS The vast majority of peer-recovery coaches were satisfied with the overall quality of the training and their training experience (96.8%). Around 95% agreed that the training enhanced their skills in the topic area and 93% agreed that the training was relevant to substance use disorder treatment at the 6-month post training survey. Majority of clients were from low-income, minority demographics that had a high prevalence history of incarceration, homelessness, and inconsistent employment. At 6-month follow-up, they reported a 22% increase in stable housing and a 25% increase in full-time/part-time employment/training program enrollment. They also demonstrated a significant decline in reported depression, anxiety, and prescribed medication use at 6-month follow-up when compared to baseline. CONCLUSIONS Clients enrolled in a tailored evidence based peer-led program decreased their psychiatric symptoms and increased their housing stability and employment. Study outcomes support the use of an integrated peer-led support for increasing engagement in care for adults experiencing substance use disorders.
Collapse
Affiliation(s)
| | - Sanjukta Modak
- Family Medicine, Baylor College of Medicine, Houston, TX, USA
| | - Samuel McMaster
- Family Medicine, Baylor College of Medicine, Houston, TX, USA
| | - Roger Zoorob
- Family Medicine, Baylor College of Medicine, Houston, TX, USA
| | - Sandra Gonzalez
- Family Medicine, Baylor College of Medicine, Houston, TX, USA
| |
Collapse
|
31
|
Gonzalez S, Taïeb D, Guedj E, Le Coz P, Cammilleri S. To what extent has the reorganization of nuclear medicine activities during the COVID-19 pandemic fulfilled medical ethics? Eur J Nucl Med Mol Imaging 2020; 48:3-5. [PMID: 32851417 PMCID: PMC7449782 DOI: 10.1007/s00259-020-05008-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2020] [Accepted: 08/18/2020] [Indexed: 01/20/2023]
Affiliation(s)
- Sandra Gonzalez
- Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, La Timone University Hospital, Marseille, France. .,Service de Médecine Nucléaire, Centre hospitalo-universitaire de la Timone, Centre Européen de Recherche en Imagerie Médicale (CERIMED), Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France.
| | - David Taïeb
- Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, La Timone University Hospital, Marseille, France.,Service de Médecine Nucléaire, Centre hospitalo-universitaire de la Timone, Centre Européen de Recherche en Imagerie Médicale (CERIMED), Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France.,Aix-Marseille Université INSERM, UMR1068, CRCM, Marseille, France
| | - Eric Guedj
- Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, La Timone University Hospital, Marseille, France.,Service de Médecine Nucléaire, Centre hospitalo-universitaire de la Timone, Centre Européen de Recherche en Imagerie Médicale (CERIMED), Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France.,Institut Fresnel, Aix-Marseille Université, CRCM, Ecole Centrale Marseille, UMR 7249, Marseille, France
| | - Pierre Le Coz
- Espace Ethique Méditerranéen, Timone University Hospital, UMR 7268 ADéS, Aix-Marseille University-EFS-CNRS, 13385, Marseille, France
| | - Serge Cammilleri
- Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, La Timone University Hospital, Marseille, France.,Service de Médecine Nucléaire, Centre hospitalo-universitaire de la Timone, Centre Européen de Recherche en Imagerie Médicale (CERIMED), Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France.,Institut Fresnel, Aix-Marseille Université, CRCM, Ecole Centrale Marseille, UMR 7249, Marseille, France
| |
Collapse
|
32
|
Weinstock A, Gallego-Delgado J, Gomes C, Sherman J, Nikain C, Gonzalez S, Fisher E, Rodriguez A. Tamoxifen activity against Plasmodium in vitro and in mice. Malar J 2019; 18:378. [PMID: 31775753 PMCID: PMC6882195 DOI: 10.1186/s12936-019-3012-7] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2019] [Accepted: 11/16/2019] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Tamoxifen is an oestrogen receptor modulator that is widely used for the treatment of early stage breast cancer and reduction of recurrences. Tamoxifen is also used as a powerful research tool for controlling gene expression in the context of the Cre/loxP site-specific recombination system in conditional mutant mice. METHODS To determine whether the administration of tamoxifen affects Plasmodium growth and/or disease outcome in malaria, in vitro studies assessing the effect of tamoxifen and its active metabolite 4-hydroxytamoxifen on Plasmodium falciparum blood stages were performed. Tamoxifen effects were also evaluated in vivo treating C57/B6 mice infected with Plasmodium berghei (ANKA strain), which is the standard animal model for the study of cerebral malaria. RESULTS Tamoxifen and its active metabolite, 4-hydroxytamoxifen, show activity in vitro against P. falciparum (16.7 to 5.8 µM IC50, respectively). This activity was also confirmed in tamoxifen-treated mice infected with P. berghei, which show lower levels of parasitaemia and do not develop signs of cerebral malaria, compared to control mice. Mice treated with tamoxifen for 1 week and left untreated for an additional week before infection showed similar parasitaemia levels and signs of cerebral malaria as control untreated mice. CONCLUSIONS Tamoxifen and its active metabolite, 4-hydroxytamoxifen, have significant activity against the human parasite P. falciparum in vitro and the rodent parasite P. berghei in vivo. This activity may be useful for prevention of malaria in patients taking this drug chronically, but also represents a major problem for scientists using the conditional mutagenic Cre/LoxP system in the setting of rodent malaria. Allowing mice to clear tamoxifen before starting a Plasmodium infection allows the use the Cre/LoxP conditional mutagenic system to investigate gene function in specific tissues.
Collapse
Affiliation(s)
- Ada Weinstock
- Departments of Medicine (Cardiology) and Cell Biology, and the Marc and Ruti Bell Program in Vascular Biology, New York University School of Medicine, New York, NY, 10016, USA
| | - Julio Gallego-Delgado
- Department of Biological Sciences, Lehman College, City University of New York, Bronx, New York, NY, 10468, USA. .,Ph.D. Program in Biology, The Graduate Center, The City University of New York, New York, NY, 10016, USA. .,Department of Microbiology, New York University School of Medicine, New York, NY, 10016, USA.
| | - Cláudia Gomes
- Department of Microbiology, New York University School of Medicine, New York, NY, 10016, USA
| | - Julian Sherman
- Department of Microbiology, New York University School of Medicine, New York, NY, 10016, USA
| | - Cyrus Nikain
- Departments of Medicine (Cardiology) and Cell Biology, and the Marc and Ruti Bell Program in Vascular Biology, New York University School of Medicine, New York, NY, 10016, USA
| | - Sandra Gonzalez
- Department of Microbiology, New York University School of Medicine, New York, NY, 10016, USA
| | - Edward Fisher
- Departments of Medicine (Cardiology) and Cell Biology, and the Marc and Ruti Bell Program in Vascular Biology, New York University School of Medicine, New York, NY, 10016, USA
| | - Ana Rodriguez
- Department of Microbiology, New York University School of Medicine, New York, NY, 10016, USA
| |
Collapse
|
33
|
Jove M, Moran T, Teule A, Menendez M, Gausachs M, Vilariño N, Sánchez RP, Cirauqui B, Estival A, Carcereny E, Domenech M, Navarro M, Bosch-Barrera J, Fina C, Izquierdo A, Ruffinelli J, Varela M, Mesia C, Hernandez A, Gonzalez S, Lazaro C, Brunet J, Nadal E. P1.01-54 Somatic Genome Alterations in Lung Cancer Patients Diagnosed with Li Fraumeni Syndrome. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.769] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
34
|
Vaz Salgado MÁ, Rodríguez Sánchez Á, Fernandez Perez I, Quintanar T, Navarro Martin M, Vieito Villar M, Cano J, Gonzalez S, Ros S, Herrero Ibañez A, Ivars M, Lloret M, Alonso M, Moya I, Luque R, Benavides M, Gutiérrez Toribio M, García-Gómez J, Esteban Villarrubia J, Torres Jimenez J. Spanish survey of treatment recommendations for elderly patients with glioblastoma. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz243.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
35
|
Wennervirta J, Koivunoro H, Gonzalez S, Provenzano L, Kankaanranta L, Vaalavirta L, Joensuu H. A Retrospective Study of Predictors for Radiation Induced Severe Oral Mucositis in BPA-Mediated BNCT of Head and Neck Cancer Patients. Int J Radiat Oncol Biol Phys 2019. [DOI: 10.1016/j.ijrobp.2019.06.1601] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
36
|
Velez ID, Santacruz E, Kutcher SC, Duque SL, Uribe A, Barajas J, Gonzalez S, Patino AC, Zuluaga L, Martínez L, Muñoz E, Mejia MC, Arbelaez MP, Pulido H, Jewell NP, Dufault SM, O'Neill SL, Simmons CP, Anders KL, Tanamas SK. The impact of city-wide deployment of Wolbachia-carrying mosquitoes on arboviral disease incidence in Medellín and Bello, Colombia: study protocol for an interrupted time-series analysis and a test-negative design study. F1000Res 2019; 8:1327. [PMID: 34900237 PMCID: PMC8637243 DOI: 10.12688/f1000research.19858.1] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 05/13/2020] [Indexed: 08/23/2023] Open
Abstract
Background: Dengue, chikungunya and Zika are viral infections transmitted by Aedes aegypti mosquitoes, and present major public health challenges in tropical regions. Traditional vector control methods have been ineffective at halting disease transmission. The World Mosquito Program has developed a novel approach to arbovirus control using Ae. aegypti stably transfected with the Wolbachia bacterium, which have significantly reduced ability to transmit dengue, Zika and chikungunya in laboratory experiments. Field releases in eight countries have demonstrated Wolbachia establishment in local Ae. aegypti populations. Methods: We describe a pragmatic approach to measuring the epidemiological impact of city-wide Wolbachia deployments in Bello and Medellín, Colombia. First, an interrupted time-series analysis will compare the incidence of dengue, chikungunya and Zika case notifications before and after Wolbachia releases, across the two municipalities. Second, a prospective case-control study using a test-negative design will be conducted in one quadrant of Medellín. Three of the six contiguous release zones in the case-control area were allocated to receive the first Wolbachia deployments in the city and three to be treated last, approximating a parallel two-arm trial for the >12-month period during which Wolbachia exposure remains discordant. Allocation, although non-random, aimed to maximise balance between arms in historical dengue incidence and demographics. Arboviral disease cases and arbovirus-negative controls will be enrolled concurrently from febrile patients presenting to primary care, with case/control status classified retrospectively following laboratory diagnostic testing. Intervention effect is estimated from an aggregate odds ratio comparing Wolbachia-exposure odds among test-positive cases versus test-negative controls. Discussion: The study findings will add to an accumulating body of evidence from global field sites on the efficacy of the Wolbachia method in reducing arboviral disease incidence, and can inform decisions on wider public health implementation of this intervention in the Americas and beyond. Trial registration: ClinicalTrials.gov: NCT03631719. Registered on 15 August 2018.
Collapse
Affiliation(s)
- Ivan D. Velez
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Eduardo Santacruz
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Simon C. Kutcher
- World Mosquito Program, Institute of Vector Borne Disease, Monash University, Melbourne, VIC, Australia
| | - Sandra L. Duque
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Alexander Uribe
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Jovany Barajas
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Sandra Gonzalez
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | | | - Lina Zuluaga
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Luis Martínez
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Estefanía Muñoz
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | | | | | | | - Nicholas P. Jewell
- Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA, USA
- Centre for Statistical Methodology, London School of Hygiene & Tropical Medicine, London, UK
| | - Suzanne M Dufault
- Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA, USA
| | - Scott L. O'Neill
- World Mosquito Program, Institute of Vector Borne Disease, Monash University, Melbourne, VIC, Australia
| | - Cameron P. Simmons
- World Mosquito Program, Institute of Vector Borne Disease, Monash University, Melbourne, VIC, Australia
| | - Katherine L. Anders
- World Mosquito Program, Institute of Vector Borne Disease, Monash University, Melbourne, VIC, Australia
| | - Stephanie K. Tanamas
- World Mosquito Program, Institute of Vector Borne Disease, Monash University, Melbourne, VIC, Australia
| |
Collapse
|
37
|
Velez ID, Santacruz E, Kutcher SC, Duque SL, Uribe A, Barajas J, Gonzalez S, Patino AC, Zuluaga L, Martínez L, Muñoz E, Mejia MC, Arbelaez MP, Pulido H, Jewell NP, Dufault SM, O'Neill SL, Simmons CP, Anders KL, Tanamas SK. The impact of city-wide deployment of Wolbachia-carrying mosquitoes on arboviral disease incidence in Medellín and Bello, Colombia: study protocol for an interrupted time-series analysis and a test-negative design study. F1000Res 2019; 8:1327. [PMID: 34900237 PMCID: PMC8637243 DOI: 10.12688/f1000research.19858.2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 05/13/2020] [Indexed: 12/20/2022] Open
Abstract
Background: Dengue, chikungunya and Zika are viral infections transmitted by Aedes aegypti mosquitoes, and present major public health challenges in tropical regions. Traditional vector control methods have been ineffective at halting disease transmission. The World Mosquito Program has developed a novel approach to arbovirus control using Ae. aegypti stably transfected with the Wolbachia bacterium, which have significantly reduced ability to transmit dengue, Zika and chikungunya in laboratory experiments. Field releases in eight countries have demonstrated Wolbachia establishment in local Ae. aegypti populations. Methods: We describe a pragmatic approach to measuring the epidemiological impact of city-wide Wolbachia deployments in Bello and Medellín, Colombia. First, an interrupted time-series analysis will compare the incidence of dengue, chikungunya and Zika case notifications before and after Wolbachia releases, across the two municipalities. Second, a prospective case-control study using a test-negative design will be conducted in one quadrant of Medellín. Three of the six contiguous release zones in the case-control area were allocated to receive the first Wolbachia deployments in the city and three to be treated last, approximating a parallel two-arm trial for the >12-month period during which Wolbachia exposure remains discordant. Allocation, although non-random, aimed to maximise balance between arms in historical dengue incidence and demographics. Arboviral disease cases and arbovirus-negative controls will be enrolled concurrently from febrile patients presenting to primary care, with case/control status classified retrospectively following laboratory diagnostic testing. Intervention effect is estimated from an aggregate odds ratio comparing Wolbachia-exposure odds among test-positive cases versus test-negative controls. Discussion: The study findings will add to an accumulating body of evidence from global field sites on the efficacy of the Wolbachia method in reducing arboviral disease incidence, and can inform decisions on wider public health implementation of this intervention in the Americas and beyond. Trial registration: ClinicalTrials.gov: NCT03631719. Registered on 15 August 2018.
Collapse
Affiliation(s)
- Ivan D Velez
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Eduardo Santacruz
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Simon C Kutcher
- World Mosquito Program, Institute of Vector Borne Disease, Monash University, Melbourne, VIC, Australia
| | - Sandra L Duque
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Alexander Uribe
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Jovany Barajas
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Sandra Gonzalez
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | | | - Lina Zuluaga
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Luis Martínez
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | - Estefanía Muñoz
- World Mosquito Program, Universidad de Antioquia, Medellin, Colombia
| | | | | | | | - Nicholas P Jewell
- Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.,Centre for Statistical Methodology, London School of Hygiene & Tropical Medicine, London, UK
| | - Suzanne M Dufault
- Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA, USA
| | - Scott L O'Neill
- World Mosquito Program, Institute of Vector Borne Disease, Monash University, Melbourne, VIC, Australia
| | - Cameron P Simmons
- World Mosquito Program, Institute of Vector Borne Disease, Monash University, Melbourne, VIC, Australia
| | - Katherine L Anders
- World Mosquito Program, Institute of Vector Borne Disease, Monash University, Melbourne, VIC, Australia
| | - Stephanie K Tanamas
- World Mosquito Program, Institute of Vector Borne Disease, Monash University, Melbourne, VIC, Australia
| |
Collapse
|
38
|
Saknite I, Gill M, Alessi-Fox C, Byrne M, Jagasia M, Gonzalez S, Ardigo M, Tkaczyk ER. Features of cutaneous acute graft-versus-host disease by reflectance confocal microscopy. Br J Dermatol 2019; 181:829-831. [PMID: 30927259 DOI: 10.1111/bjd.17921] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- I Saknite
- Vanderbilt University Medical Center, Nashville, TN, U.S.A
| | - M Gill
- Department of Pathology, SUNY Downstate Medical Center, Brooklyn, NY, U.S.A
| | | | - M Byrne
- Vanderbilt University Medical Center, Nashville, TN, U.S.A
| | - M Jagasia
- Vanderbilt University Medical Center, Nashville, TN, U.S.A
| | | | | | - E R Tkaczyk
- Vanderbilt University Medical Center, Nashville, TN, U.S.A.,Dermatology Service and Research Service, Tennessee Valley Healthcare System, Department of Veterans Affairs, Nashville, TN, U.S.A
| |
Collapse
|
39
|
Cambra MJ, Moreno F, Sanz X, Anglada L, Mollà M, Reyes V, Arenas M, Pedro A, Ballester R, García V, Casals J, Cusidó M, Jimenez C, Escribà JM, Macià M, Solé JM, Arcusa A, Seguí MA, Gonzalez S, Farrús B, Biete A. Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients. Clin Transl Oncol 2019; 22:670-680. [PMID: 31264148 DOI: 10.1007/s12094-019-02168-x] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2018] [Accepted: 06/19/2019] [Indexed: 12/01/2022]
Abstract
PURPOSE To evaluate the effect of boost radiotherapy on ipsilateral breast tumor recurrence (IBTR) for ductal carcinoma in situ (DCIS) after breast-conserving surgery and whole breast radiotherapy (WBRT) with or without boost. METHODS AND MATERIALS Retrospective, multicentre study of 622 patients (624 tumors) diagnosed with pure DCIS from 1993-2011. RESULTS Most tumors (377/624; 60.4%) received a boost. At a median follow-up of 8.8 years, IBTR occurred in 64 cases (10.3%). A higher percentage of patients with risk factors for IBTR received a boost (p < 0.05). Boost was not associated with lower rates of IBTR than WBRT alone (HR 0.75, 95% CI 0.42-1.35). On the univariate analyses, IBTR was significantly associated with tumor size (11-20 mm, HR 2.32, 95% CI 1.27-4.24; and > 20 mm, HR 2.10, 95% CI 1.14-3.88), re-excision (HR 1.76, 95% CI 1.04-2.96), and tamoxifen (HR 2.03, 95% CI 1.12-3.70). Boost dose > 16 Gy had a protective effect (HR 0.39, 95% CI 0.187-0.824). Multivariate analyses confirmed the independent associations between IBTR and 11-20 mm (p = 0.02) and > 20 mm (p = 0.009) tumours, and re-excision (p = 0.006). On the margin-stratified multivariate analysis, tamoxifen was a poor prognostic factor in the close/positive margin subgroup (HR 4.28 95% CI 1.23-14.88), while the highest boost dose ( > 16 Gy) had a significant positive effect (HR 0.34, 95% CI 0.13-0.86) in the negative margin subgroup. CONCLUSIONS Radiotherapy boost did not improve the risk of IBTR. Boost radiotherapy was more common in patients with high-risk disease. Tumor size and re-excision were significant independent prognostic factors.
Collapse
Affiliation(s)
- M J Cambra
- Department of Radiation Oncology, Hospital Universitari General de Catalunya-Grupo Quirónsalud (IOV-HGC-Quironsalud), Carrer Pedro i Pons 1, 08195, Sant Cugat del Vallés, Barcelona, Spain.
| | - F Moreno
- Department of Radiation Oncology, Institut Català d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat, Avda de la Granvia, 199, 08908, Barcelona, Spain
| | - X Sanz
- Department of Radiation Oncology, Parc de Salut MAR, Passeig Marítim 25-29, 08003, Barcelona, Spain
| | - L Anglada
- Department of Radiation Oncology, ICO Girona, Avda de França, s/n, 17007, Girona, Spain
| | - M Mollà
- Department of Radiation Oncology, Hospital Vall d'Hebrón, Pg Vall d'Hebron 119, 129, 08035, Barcelona, Spain.,Department of Radiation Oncology, Hospital Clìnic, Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain
| | - V Reyes
- Department of Radiation Oncology, Hospital Vall d'Hebrón, Pg Vall d'Hebron 119, 129, 08035, Barcelona, Spain
| | - M Arenas
- Department of Radiation Oncology, Hospital Universitari Sant Joan Reus, Avda del Dr. Josep Laporte, 2, 43204, Reus, Tarragona, Spain
| | - A Pedro
- Department of Radiation Oncology, Hospital Plató, c/Plató, 21, 08006, Barcelona, Spain
| | - R Ballester
- Department of Radiation Oncology, Institut Català D'Oncologia-Badalona, Carretera del Canyet, s/n, 08916, Badalona, Barcelona, Spain
| | - V García
- Department of Radiation Oncology, Hospital Arnau de Vilanova, Avda Alcalde Rovira Roure, 80, 25198, Lleida, Spain
| | - J Casals
- Department of Radiation Oncology, Hospital Quirón, Plaça Alfonso Comín, 5, 08023, Barcelona, Spain
| | - M Cusidó
- Department of Gynecology and Obstetrics, Hospital Universitari Dexeus-Grupo Quirónsalud, c/Sabino Arana, 5-19, 08028, Barcelona, Spain
| | - C Jimenez
- Biostatistics and Bioinformatic Expert, Olesa de Montserrat, c/Urgell 55 A, 08640, Barcelona, Spain
| | - J M Escribà
- Catalan Cancer Registry, Cancer Planning Directorate, L'Hospitalet de Llobregat, Avda de La Granvia, s/n, 08908, Barcelona, Spain.,Department of Clinical Sciences, University of Barcelona, Barcelona, Spain
| | - M Macià
- Department of Radiation Oncology, Institut Català d'Oncologia L'Hospitalet, L'Hospitalet de Llobregat, Avda de la Granvia, 199, 08908, Barcelona, Spain
| | - J M Solé
- Department of Radiation Oncology, Consorci Sanitari de Terrassa, Ctra. Torrebonica s/n, 08227, Terrassa, Barcelona, Spain
| | - A Arcusa
- Department of Medical Oncology, Ctra. Torrebonica s/n, Consorci Sanitari de Terrassa, 08227, Terrassa, Barcelona, Spain
| | - M A Seguí
- Department of Medical Oncology, Corporació Sanitaria Parc Taulí, Parc Taulí 1, 08208, Sabadell, Barcelona, Spain
| | - S Gonzalez
- Department of Medical Oncology, Hospital Universitari Mútua de Terrassa, Plaça del Doctor Robert, 5, 08221, Terrassa, Barcelona, Spain
| | - B Farrús
- Department of Radiation Oncology, Hospital Clìnic, Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain
| | - A Biete
- Department of Radiation Oncology, Hospital Clìnic, Universitat de Barcelona, Villarroel 170, 08036, Barcelona, Spain
| |
Collapse
|
40
|
Maarouf M, Costello CM, Gonzalez S, Angulo I, Curiel-Lewandrowski CN, Shi VY. In Vivo Reflectance Confocal Microscopy: Emerging Role in Noninvasive Diagnosis and Monitoring of Eczematous Dermatoses. Actas Dermosifiliogr (Engl Ed) 2019; 110:626-636. [PMID: 31202471 DOI: 10.1016/j.ad.2018.08.008] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2018] [Revised: 08/07/2018] [Accepted: 08/08/2018] [Indexed: 11/20/2022] Open
Abstract
Dermatologic diagnosis and monitoring have been dependent largely on visual grading. A skin biopsy is performed in case of diagnostic uncertainty, but can be traumatic, and results are delayed due to time for specimen transport and processing. Biopsies also destroy specimens, prohibiting lesion evolution monitoring. In vivo reflectance confocal microscopy (RCM) offers a diagnostic alternative to skin biopsy. RCM captures real-time, high-resolution images, and has been piloted for the evaluation of various dermatologic conditions. Identification of unique RCM features may distinguish dermatoses with similar clinical morphologies. Allergic contact dermatitis (ACD) and irritant contact dermatitis (ICD) are diagnosed by patch testing that currently uses a subjective scoring system. RCM has increasingly been studied for early detection and severity grading of CD. Common RCM features shared by ACD and ICD are stratum corneum disruption, vesicle formation, exocytosis, spongiosis, and parakeratosis. Features unique to ACD are vasodilation, increased epidermal thickness, intercellular edema, and acanthosis. Features unique to ICD are detached corneocytes and targetoid keratinocytes. This review summarizes the use of RCM in evaluating contact eccematous conditions and aims to spark future research and interest in this promising tool.
Collapse
Affiliation(s)
- M Maarouf
- Facultad de Medicina, Universidad de Arizona, Tucson, Arizona, Estados Unidos
| | - C M Costello
- Departamento de Dermatología, Clínica Mayo, Scottsdale, Arizona, Estados Unidos
| | - S Gonzalez
- Servicio de Dermatología, Hospital Ramón y Cajal, Universidad de Alcalá, Madrid, España
| | - I Angulo
- Departamento de Medicina, Universidad de ArizonaTucson, Arizona, Estados Unidos
| | - C N Curiel-Lewandrowski
- División de Dermatología, Departamento de Medicina, Universidad de Arizona, Tucson, Arizona, Estados Unidos
| | - V Y Shi
- División de Dermatología, Departamento de Medicina, Universidad de Arizona, Tucson, Arizona, Estados Unidos.
| |
Collapse
|
41
|
Cinotti E, Fiorani D, Labeille B, Gonzalez S, Debarbieux S, Agozzino M, Ardigò M, Lacarrubba F, Farnetani F, Carrera C, Cevenini G, Le Duff F, Tognetti L, Pellacani G, Rubegni P, Perrot JL. The integration of dermoscopy and reflectance confocal microscopy improves the diagnosis of lentigo maligna. J Eur Acad Dermatol Venereol 2019; 33:e372-e374. [PMID: 31074539 DOI: 10.1111/jdv.15669] [Citation(s) in RCA: 22] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- E Cinotti
- Dermatology Section, Department of Medical, Surgical and Neurological Science, S. Maria alle Scotte Hospital, University of Siena, Siena, Italy
| | - D Fiorani
- Dermatology Section, Department of Medical, Surgical and Neurological Science, S. Maria alle Scotte Hospital, University of Siena, Siena, Italy
| | - B Labeille
- Department of Dermatology, University Hospital of St-Etienne, Saint-Etienne, France
| | - S Gonzalez
- Medicine and Medical Specialities Department, Alcalá University, Madrid, Spain
| | - S Debarbieux
- Departments of Dermatology, Centre Hospitalier Lyon Sud, Pierre Benite, France
| | - M Agozzino
- Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy
| | - M Ardigò
- Clinical Dermatology, San Gallicano Dermatological Institute, Rome, Italy
| | - F Lacarrubba
- Dermatology Clinic, University of Catania, Catania, Italy
| | - F Farnetani
- Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy
| | - C Carrera
- Melanoma Unit, Department of Dermatology, Hospital Clínic de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona University, Barcelona, Spain
| | - G Cevenini
- Department of Medical Biotechnologies, University of Siena, Siena, Italy
| | - F Le Duff
- Department of Dermatology, Clinical Research Center, Hopital Archet 2, Nice, France
| | - L Tognetti
- Dermatology Section, Department of Medical, Surgical and Neurological Science, S. Maria alle Scotte Hospital, University of Siena, Siena, Italy.,Department of Medical Biotechnologies, University of Siena, Siena, Italy
| | - G Pellacani
- Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy
| | - P Rubegni
- Dermatology Section, Department of Medical, Surgical and Neurological Science, S. Maria alle Scotte Hospital, University of Siena, Siena, Italy
| | - J L Perrot
- Department of Dermatology, University Hospital of St-Etienne, Saint-Etienne, France
| |
Collapse
|
42
|
Tenkku Lepper L, King D, Doll J, Gonzalez S, Mitchell A, Hartje J. Partnering with the Health Professions to Promote Prevention of an Alcohol-Exposed Pregnancy: Lessons Learned from an Academic⁻Organizational Collaborative. Int J Environ Res Public Health 2019; 16:ijerph16101702. [PMID: 31096556 PMCID: PMC6572076 DOI: 10.3390/ijerph16101702] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/12/2019] [Revised: 05/03/2019] [Accepted: 05/10/2019] [Indexed: 11/24/2022]
Abstract
Background: Evidence-based strategies exist to train healthcare professionals to ask their patients and clients about alcohol use, and are successful. Implementation of these strategies utilizing a system-level approach has not been conducted nationwide. This case study reports on the success of academic partnerships with national health professional organizations to increase adoption of evidence-based strategies to prevent alcohol-exposed pregnancies. Methods: Authors reviewed and summarized multi-level strategies created as part of the developmental phase of this project in order to report successes and challenges. We applied the three principles of reflection, sense-making, and reciprocal learning, as identified in the practice change literature, to synthesize our experience. Results: There were five primary lessons learned as a result of this work: Development of technology-based training websites requires significant time to design, implement, and test; project ‘mission-drift’ is inevitable, but not necessarily unwelcome; time and effort is required to create and sustain functioning workgroups when there are different organizational cultures; and changing real-world practice is hard to do, yet changing the conversation on screening and brief intervention is possible. Conclusions: Use of multi-level strategies within an academic–professional organization model was successful in promoting awareness and education of healthcare professionals in the prevention of alcohol-exposed pregnancies.
Collapse
Affiliation(s)
| | - Diane King
- Center for Behavioral health Research and Services, University of Alaska Anchorage, Anchorage, AK 99508, USA.
| | - Joy Doll
- Center for Interprofessional Practice, Education and Research, Creighton University, Omaha, NE 68178, USA.
| | - Sandra Gonzalez
- Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX 77098, USA.
| | - Ann Mitchell
- School of Nursing, University of Pittsburgh, Pittsburgh, PA 15261, USA.
| | - Joyce Hartje
- Center for the Application of Substance Abuse Technologies (CASAT), University of Nevada, Reno, NV 89557, USA.
| |
Collapse
|
43
|
Santos-Juanes J, Fernández-Vega I, Lorenzo-Herrero S, Sordo-Bahamonde C, Martínez-Camblor P, García-Pedrero JM, Vivanco B, Galache-Osuna C, Vazquez-Lopez F, Gonzalez S, Rodrigo JP. Lectin-like transcript 1 (LLT1) expression is associated with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma. Arch Dermatol Res 2019; 311:369-376. [PMID: 30955082 DOI: 10.1007/s00403-019-01916-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2018] [Revised: 03/22/2019] [Accepted: 03/30/2019] [Indexed: 12/19/2022]
Abstract
The interaction of lectin-like transcript 1 (LLT1) with CD161 inhibits Natural Killer cell activation. Overexpression of LLT1 contributes to the immunosuppressive properties of tumor cells. However, there are little data about LLT1 expression in human solid tumors. The objective of this paper is to investigate the relationship between LLT1 expression with the clinicopathologic features and its impact on the prognosis of head and neck cutaneous squamous cell carcinoma (cSCC). LLT1 expression was analyzed on paraffin-embedded tissue samples obtained from 100 patients with cSCC by immunohistochemistry. The estimator of Fine and Gray was used to estimate the cumulative incidence curves for relapse. Proportional Hazard models and Hazard ratios (HRs) were used for studying the risk of tumor relapse and mortality. LLT1 strong expression was a significant risk factor for nodal metastasis with crude and adjusted ratios (HRs) of 3.40 (95% CI 1.39-9.28) and 3.25 (95% CI 1.15-9.16); and for cSCC specific death of 6.17 (95% CI 1.79-21.2) and 6.10 (95% CI 1.45-25.7). Strong LLT1 expression is an independent predictor of nodal metastasis and poor disease-specific survival and it might be helpful for risk stratification of patients with cSCC.
Collapse
Affiliation(s)
- J Santos-Juanes
- Service of Dermatology, Hospital Universitario Central de Asturias, Oviedo, Spain. .,Departamento de Medicina, Universidad de Oviedo, Oviedo, Spain. .,Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
| | - I Fernández-Vega
- Service of Pathology, Hospital Universitario Central de Asturias, Oviedo, Spain.,Departamento de Cirugía y especialidades Médico-quirúrgicas, Universidad de Oviedo, Oviedo, Spain
| | - S Lorenzo-Herrero
- Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.,Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain.,Department of Functional Biology, University of Oviedo, Oviedo, Spain
| | - C Sordo-Bahamonde
- Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.,Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain.,Department of Functional Biology, University of Oviedo, Oviedo, Spain
| | - P Martínez-Camblor
- Geisel School of Medicine at Dartmouth, Dartmouth College, Hannover, NH, USA
| | - J M García-Pedrero
- Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.,Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain
| | - B Vivanco
- Service of Pathology, Hospital Universitario Central de Asturias, Oviedo, Spain.,Departamento de Cirugía y especialidades Médico-quirúrgicas, Universidad de Oviedo, Oviedo, Spain
| | - C Galache-Osuna
- Service of Dermatology, Hospital Universitario Central de Asturias, Oviedo, Spain
| | - F Vazquez-Lopez
- Service of Dermatology, Hospital Universitario Central de Asturias, Oviedo, Spain.,Departamento de Medicina, Universidad de Oviedo, Oviedo, Spain
| | - S Gonzalez
- Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.,Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain.,Department of Functional Biology, University of Oviedo, Oviedo, Spain
| | - J P Rodrigo
- Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.,Instituto Universitario de Oncología del Principado de Asturias, Oviedo, Spain.,Department of Otolaryngology, Hospital Universitario Central de Asturias and Oviedo, Oviedo, Spain.,CIBERONC, Madrid, Spain
| |
Collapse
|
44
|
Bortolussi S, Postuma I, Protti N, Fatemi S, Magni C, Gonzalez S, Altieri S. EP-1885 Neutron beam design and dosimetric evaluation for accelerator-based Boron Neutron Capture Therapy. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32305-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
45
|
Coral DF, Soto PA, Blank V, Veiga A, Spinelli E, Gonzalez S, Saracco GP, Bab MA, Muraca D, Setton-Avruj PC, Roig A, Roguin L, Fernández van Raap MB. Nanoclusters of crystallographically aligned nanoparticles for magnetic thermotherapy: aqueous ferrofluid, agarose phantoms and ex vivo melanoma tumour assessment. Nanoscale 2018; 10:21262-21274. [PMID: 30418464 DOI: 10.1039/c8nr07453d] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/21/2023]
Abstract
Magnetic hyperthermia is an oncological therapy where magnetic nanostructures, under a radiofrequency field, act as heat transducers increasing tumour temperature and killing cancerous cells. Nanostructure heating efficiency depends both on the field conditions and on the nanostructure properties and mobility inside the tumour. Such nanostructures are often incorrectly bench-marketed in the colloidal state and using field settings far off from the recommended therapeutic values. Here, we prepared nanoclusters composed of iron oxide magnetite nanoparticles crystallographically aligned and their specific absorption rate (SAR) values were calorimetrically determined in physiological fluids, agarose-gel-phantoms and ex vivo tumours extracted from mice challenged with B16-F0 melanoma cells. A portable, multipurpose applicator using medical field settings; 100 kHz and 9.3 kA m-1, was developed and the results were fully analysed in terms of nanoclusters' structural and magnetic properties. A careful evaluation of the nanoclusters' heating capacity in the three milieus clearly indicates that the SAR values of fluid suspensions or agarose-gel-phantoms are not adequate to predict the real tissue temperature increase or the dosage needed to heat a tumour. Our results show that besides nanostructure mobility, perfusion and local thermoregulation, the nanostructure distribution inside the tumour plays a key role in effective heating. A suppression of the magnetic material effective heating efficiency appears in tumour tissue. In fact, dosage had to be increased considerably, from the SAR values predicted from fluid or agarose, to achieve the desired temperature increase. These results represent an important contribution towards the design of more efficient nanostructures and towards the clinical translation of hyperthermia.
Collapse
Affiliation(s)
- D F Coral
- Instituto de Física de La Plata (IFLP - CONICET), Departamento de Física, Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), c.c. 67, 1900 La Plata, Argentina.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
46
|
Scope A, Dusza SW, Pellacani G, Gill M, Gonzalez S, Marchetti MA, Rabinovitz HS, Marghoob AA, Alessi-Fox C, Halpern AC. Accuracy of tele-consultation on management decisions of lesions suspect for melanoma using reflectance confocal microscopy as a stand-alone diagnostic tool. J Eur Acad Dermatol Venereol 2018; 33:439-446. [PMID: 30242916 DOI: 10.1111/jdv.15257] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2018] [Accepted: 07/26/2018] [Indexed: 11/28/2022]
Abstract
BACKGROUND Diagnostic accuracy of reflectance confocal microscopy (RCM) as a stand-alone diagnostic tool for suspect skin lesions has not been extensively studied. OBJECTIVE Primary aim was to measure experts' accuracy in RCM-based management decisions. Secondary aim was to identify melanoma-specific RCM features. METHODS The study enrolled patients ≥18 years that underwent biopsy of skin lesions clinically suspected to be melanoma. One hundred lesions imaged by RCM were randomly selected from 439 lesions prospectively collected at four pigmented lesion clinics. The study data set included 23 melanomas, three basal cell and two squamous cell carcinomas, 11 indeterminate melanocytic lesions and 61 benign lesions including 50 nevi. Three expert RCM evaluators were blinded to clinical or dermoscopic images, and to the final histopathological diagnosis. Evaluators independently issued a binary RCM-based management decision, 'biopsy' vs. 'observation'; these decisions were scored against histopathological diagnosis, with 'biopsy' as the correct management decision for malignant and indeterminate lesions. A subset analysis of 23 melanomas and 50 nevi with unequivocal histopathological diagnosis was performed to identify melanoma-specific RCM features. RESULTS Sensitivity, specificity and diagnostic accuracy were 74%, 67% and 70% for reader 1, 46%, 84% and 69% for reader 2, and 72%, 46% and 56% for reader 3, respectively. The overall kappa for management decisions was 0.34. Readers had unanimous agreement on management for 50 of the 100 lesions. Non-specific architecture, non-visible papillae, streaming of nuclei, coarse collagen fibres and abnormal vasculature showed a significant association with melanoma in the evaluation of at least two readers. CONCLUSIONS Reflectance confocal microscopy tele-consultation of especially challenging lesions, based on image review without benefit of clinical or dermoscopy images, may be associated with limited diagnostic accuracy and interobserver agreement. Architectural and stromal criteria may emerge as potentially useful and reproducible criteria for melanoma diagnosis.
Collapse
Affiliation(s)
- A Scope
- Medical Screening Institute, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.,Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - S W Dusza
- Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - G Pellacani
- Department of Dermatology, University of Modena and Reggio Emilia, Modena, Italy
| | - M Gill
- SkinMedical Research and Diagnostics, Dobbs Ferry, NY, USA.,SUNY Downstate, Brooklyn, NY, USA
| | - S Gonzalez
- Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.,Department of Medicine and Medical Specialties, University de Alcalà, Madrid, Spain
| | - M A Marchetti
- Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | | | - A A Marghoob
- Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| | - C Alessi-Fox
- Caliber Imaging and Diagnostics, Rochester, NY, USA
| | - A C Halpern
- Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
| |
Collapse
|
47
|
Gonzalez S, Guedj E, Fanti S, Lalumera E, Le Coz P, Taïeb D. Delivering PET imaging results to cancer patients: steps for handling ethical issues. Eur J Nucl Med Mol Imaging 2018; 45:2240-2241. [PMID: 30109400 DOI: 10.1007/s00259-018-4124-y] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/26/2018] [Accepted: 08/01/2018] [Indexed: 11/30/2022]
Affiliation(s)
- Sandra Gonzalez
- Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Timone University Hospital, Marseille, France.
- CERIMED, Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France.
| | - Eric Guedj
- Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Timone University Hospital, Marseille, France
- CERIMED, Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France
- Aix-Marseille Université, CNRS, Ecole Centrale Marseille, UMR 7249, Institut Fresnel, Marseille, France
| | - Stefano Fanti
- Medicina Nucleare, Policlinico S. Orsola, Università di Bologna, Bologna, Italy
| | - Elisabetta Lalumera
- Psychology Department & Philosophy of Health and Disease Research Center, Milano-Bicocca University, Milan, Italy
| | - Pierre Le Coz
- UMR 7268 ADéS, Espace Ethique Méditerranéen, Timone University Hospital, Aix-Marseille University-EFS-CNRS, 13385, Marseille, France
| | - David Taïeb
- Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Timone University Hospital, Marseille, France.
- CERIMED, Aix-Marseille Université, 264, rue Saint-Pierre, 13385, Marseille, France.
| |
Collapse
|
48
|
Gonzalez S, Parra A, Mussini S, Buchovsky A, Berberian G. Cat scratch disease in children, a five year study in a pediatric tertiary hospital. Int J Infect Dis 2018. [DOI: 10.1016/j.ijid.2018.04.4158] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
49
|
Cedeño Y, Gonzalez S, Cabrera C, Messina OG, Lopez J, de Souza M, Astudillo G. Neurocysticercosis an emerging entity in the city of Buenos Aires. Int J Infect Dis 2018. [DOI: 10.1016/j.ijid.2018.04.3854] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
50
|
del Puerto C, Navarrete-Dechent C, Molgo M, Camargo C, Borzutzky A, Gonzalez S. 维生素D受体在痣和黑色素瘤中的表达. Br J Dermatol 2018. [DOI: 10.1111/bjd.16870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|